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Due to its inherent capacity to catalyze reduction-oxidation reactions, iron is at the center stage 
of vital biological functions essential to most living organisms. Paradoxically, these same inherent 
characteristics are also responsible for the deleterious effects of iron. In the intracellular 
environment, iron is oxidized to its inert biological form by the ferroxidase activity of Ferritin 
Heavy Chain (FTH). In this Thesis we used a genetic loss of function approach in mice to 
demonstrate that FTH is essential to control the deleterious effects of iron and as such to maintain 
homeostasis in vivo. Namely we found that global deletion of the Fth allele is lethal in adult mice, 
an outcome prevented by the expression of FTH in macrophages. To investigate further the 
mechanisms by which FTH in macrophages contributes to maintain homeostasis we generated 
and characterized a genetically modified mouse strain in which FTH was tagged with a small V5 
epitope. We found that contrary to what would be expected FTH is not secreted from macrophages 
to exert its protective effect. We conclude that FTH expression in macrophages acts in a cell 
autonomous manner to support homeostasis. 
 




Devido à sua capacidade inerente em catalisar reações de oxidação-redução, o ferro desempenha 
um papel crítico em funções biológicas essenciais para a vida. Paradoxalmente, estas mesmas 
características são também responsáveis pelos efeitos nocivos do ferro. No ambiente intracelular 
o ferro é oxidado pela Ferritin Heavy Chain (FTH), tornando-o biologicamente inerte. Nesta tese, 
foi utilizada uma abordagem genética de perda-de-função em murganhos para demonstrar que 
FTH é essencial para controlar os efeitos nocivos do ferro e desta forma, sustentar a homeostasia 
in vivo. Nomeadamente, descobrimos que a deleção alélica global de Fth é letal em murganhos 
adultos e que este efeito é prevenido pela expressão de FTH em monócitos/macrófagos. Para 
investigar mais detalhadamente os mecanismos pelo qual a expressão de FTH em 
monócitos/macrófagos contribui para a manutenção da homeostasia gerámos e caracterizámos 
uma estirpe de murganhos geneticamente modificada em que FTH foi fundida com um pequeno 
epítopo V5. Ao contrário do que era esperado, foi descoberto que FTH não é secretada por 
monócitos/macrófagos para exercer o seu efeito protetor. Concluímos que a expressão de FTH 
em monócitos/macrófagos age de uma forma autónoma para suportar a homeostasia. 
 




Iron (Fe) is one of the most abundant elements on earth and the most commonly used in 
reduction-oxidation (redox) reactions in virtually all living organisms (Aisen et al., 
2001)(Gozzelino and Soares, 2014) (Figure 1.1). While the inherent capacity of Fe to catalyze 
redox reactions is used under physiologic conditions to support vital processes, such as energy 
production or oxygen transport and storage (MacKenzie et al., 2008; Wang and Pantopoulos, 
2011), Fe can also promote the generation of free radicals via the Haber-Weiss and Fenton 
reactions (Gozzelino and Soares, 2014). The final step of this reaction (Fenton) occurs through 
the reaction of ferrous Fe (Fe2+) with H2O2 which generates ferric Fe (Fe3+), OH- and hydroxyl 
radicals (OH.) (MacKenzie et al., 2008), which can cause lipid peroxidation, DNA damage/breaks 
or protein unfolding (Alkhateeb and Connor, 2013; Datz et al., 2017). This dual beneficial versus 
detrimental effect of Fe imposes an extremely delicate balance in the regulation of 
cellular/organismal Fe levels. Consequently, a set of tightly regulated mechanisms is needed to 




Figure 1.1. Systematic Fe distribution in mammals. Fe homeostasis involves a delicate balance 
between the Fe levels in different compartments. The Fe values in each box represent the total Fe 
content of each compartment and the arrows depict Fe movement across the several tissues. This 
movement is facilitated by transferrin, which is a plasma protein that acts as the main vehicle for Fe 
delivery to tissues. Because different tissues have distinct Fe requirements, the amounts of Fe vary 
greatly across tissues. The majority of Fe is located within the heme moiety of hemoglobin in RBCs 
(RBC). The liver serves as a Fe storage compartment, and as such takes up a significant amount of Fe, 
while the bone marrow and the spleen account for the bulk of the Fe being recycled and utilized for 
erythropoiesis. Accordingly, around 20-25 mg of Fe are used for physiological functions each day. 
Intestinal Fe absorption of Fe is minimal, and accounts for just 1-2 mg of Fe a day, a small proportion 
of the daily Fe requirements of the organism. Taken from (Gozzelino and Soares, 2014). 
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In mammals, around 65-70% of Fe is contained in heme (Frazer and Anderson, 2014), a 
prosthetic component of hemoglobin, myoglobin and cytochromes (Gozzelino et al., 2010; 
Gozzelino and Soares, 2014). Approximately 20% of the remaining Fe is stored by macrophages 
and hepatocytes with 10-15% being constantly utilized for cellular functions (Frazer and 
Anderson, 2014). Given that Fe is utilized at a faster rate than it is taken up from diet, systemic 
Fe levels are actively maintained through recycling mechanisms that involve the re-utilization of 
the Fe stores contained in senescent red blood cells (RBC) (Gozzelino and Soares, 2014)(Soares 
and Hamza, 2016). Nevertheless, systemic Fe 
homeostasis relies on continuous Fe uptake from 
diet, needed to compensate for Fe losses through 
epithelial desquamation, sweat or blood loss 
(Hentze et al., 2010). Fe uptake from diet occurs 
predominantly on the intestinal lumen at the level 
of the duodenum and upper jejunum, being 
absorbed essentially as non-heme Fe (90%) (Muñoz 
et al., 2011; Wang and Pantopoulos, 2011). Fe is 
absorbed in the form of Fe3+ and is reduced by 
duodenal cytochrome B (DCYTB) reductase into 
Ferrous iron (Fe2+) in the apical membrane of 
enterocytes (Vanoaica et al., 2010) (Figure 1.2). Fe 
is then imported by enterocytes by the divalent 
metal transporter 1 (DMT-1) (Vanoaica et al., 2010) 
(Figure 1.2) and either stored by intracellular 
ferritin (Vanoaica et al., 2010) or exported by 
ferroportin 1 (FPN; solute carrier family 40 member 
1; SLC40A1), a transmembrane protein expressed 
in the basolateral membrane of enterocytes 
(MacKenzie et al., 2008) (Figure 1.2). To be 
exported, Fe2+ needs to be oxidized into Fe3+, via a 
reaction catalyzed by hephaestin (HEPH), located 
in the enterocyte plasma membrane in close vicinity to FPN (Muckenthaler et al., 2017). 
Extracellular Fe3+ binds with remarkably high affinity to the plasma transferrin (TF) (Anderson et 
al., 2012)(Wang and Pantopoulos, 2011). Circulating TF-Fe complexes are bound by the 
transmembrane Fe transporters transferrin receptor 1 and 2 (TFR-1 and TFR-2) and internalized, 
via endocytosis, in a variety of cell types. Within the endo-lysosomal compartment, Fe is released 
from TF via a process that requires lysosomal acidification. This decreases TF affinity towards 
Fe3+, allowing its release into the endosomal lumen (Wang and Pantopoulos, 2011). Upon release, 
 
Figure 1.2 Intestinal Fe uptake. Simplified 
scheme illustrating dietary Fe absorption 
through the apical side of enterocytes in the 
duodenum and the major players involved in 
the transport of Fe to systemic circulation. Fe 
(III) represents ferric Fe which is reduced by 
DCYTB to ferrous Fe represented in the 
figure as Fe (II). Fe (II) can be taken up by 
enterocytes though DMT1 and according to 
physiological Fe needs, can be stored in 
Ferritin or exported into circulation through 
Ferroportin in the basal side. Fe (II) is then 
converted into Fe (III) by Hephaestin so that 
it can be posteriorly bound to transferrin and 
enter circulation. Taken and adapted from 
(De Domenico et al., 2008). 
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Fe3+ is reduced by metalloreductases, such as the six-transmembrane epithelial antigen of prostate 
family member 3 (STEAP-3) (Hentze et al., 2010) and transported to the cytoplasm by DMT-1 
(Frazer and Anderson, 2014) where it can be used by cells, for example in the heme biosynthetic 
pathway but also in other biological processes.  
Plasma Fe levels are regulated systemically by hepcidin, an acute phase protein produced 
mainly by hepatocytes and secreted into the blood stream (Ganz and Nemeth, 2015) (Figure 1.3). 
Hepcidin expression is itself regulated by a feedback mechanism loop that is sensitive to Fe 
concentration in the plasma or in the liver and that responds to erythropoietic Fe demand (Ganz, 
2011). Namely, hepcidin is produced and released systemically in response to high Fe 
concentration in plasma and mediates systemically the internalization and subsequent degradation 
of FPN. This suppresses cellular Fe export, therefore promoting intracellular Fe retention by 
ferritin (Frazer and Anderson, 2014). When Fe concentration in plasma decreases, hepcidin 
production is suppressed, allowing for FPN expression and cellular Fe release/export into plasma 
(Frazer and Anderson, 2014). More recently, decrease levels of erythropoiesis have also been 
shown to inhibit hepcidin production through the release of erythroferrone (Kautz et al., 2014).  
 
Figure 1.3. Hepcidin regulates Fe homeostasis systemically. In response to excessive Fe levels and 
inflammatory cues such as microbial peptides, IL-6, activin B and other inflammatory cytokines, 
hepcidin production in the liver increases. Hepatocytes produce and secrete the Fe hormonal regulator 
hepcidin, which acts systematically by being released into circulation and inducing ferroportin 
degradation thus promoting intracellular Fe retention. This effect inhibits ferroportin expression on a 
wide range of cells such duodenal enterocytes, splenic macrophages and hepatocytes which in turn 
reduces levels of plasma Fe bound to transferrin. This can lead to decreased levels of erythropoiesis 
prompting the release of erythroferrone from the bone marrow that inhibits hepcidin production. Taken 
from (Ganz and Nemeth, 2015).  
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Although systemic Fe levels are regulated mostly by hepcidin, it is also important to control 
Fe intracellular levels. This is achieved by the iron regulatory elements/iron regulatory proteins 
(IRE/IRP) machinery (Frazer and Anderson, 2014; Wilkinson and Pantopoulos, 2014), acting 
essentially at a post-transcriptional level to regulate the expression of proteins controlling cellular 
Fe metabolism. Briefly, this is mediated by the interaction of iron binding proteins 1 and 2 (IRP1 
and IRP2) with specific conserved cis-regulatory stem-loops present in the mRNA sequence of 
Fe-responsive genes, termed iron responsive elements (IREs) (Frazer and Anderson, 2014; 
Gozzelino and Soares, 2014). IRPs are cytosolic proteins that bind to IRE sequences present in 5’ 
and 3’ untranslated regions (UTR) on the mRNA of several proteins responsible for the 
maintenance of Fe homeostasis such as TFR-1, DMT-1, ferritin H chain (FTH), ferritin L chain 
(FTL) and FPN (177). Although each IRP protein binds to IRE sequences with similar affinity, 
each IRP is regulated in a different manner (Wilkinson and Pantopoulos, 2014). When cellular Fe 
concentration is high, IRP-1 sequesters Fe, which forms an Fe-sulfur cluster (Anderson et al., 
2012) that has the ability to act like a molecular switch preventing IRP-1 from binding to IRE 
motifs (Wilkinson and Pantopoulos, 2014). Conversely, when Fe concentration becomes limiting, 
the Fe-sulfur cluster becomes unstable and breaks down causing a conformational change that 
enables binding to the IREs (Frazer and Anderson, 2014). IRP-2 does not contain a Fe-sulfur 
cluster and can bind constitutively to IREs, when Fe level are low (Anderson et al., 2012). 
However, when intracellular Fe concentration increases, IRP-2 is degraded by an Fe-dependent 
ubiquitin-ligase called SKP1-CUL1-F-box (SCF), leading to proteasomal degradation (Frazer and 
Anderson, 2014). Depending on the cellular Fe requirements, IRPs can have opposite effects on 
the  stability of the mRNA of different Fe-responsive proteins, hence regulating their expression 
and function (Frazer and Anderson, 2014). This process is pivotal in the cellular Fe acquisition 
avoiding its cytotoxic effects while maintaining Fe availability to support vital biologic functions 
(Anderson et al., 2012). This is perhaps best illustrated for the regulation of FTH and TFR-1 
(Figure 1.4). Namely, when cellular Fe levels are low, IRP-1 and IRP-2 are actively bound to five 
IRE motifs in the 3’ UTR region of Tfr-1 mRNA promoting its stabilization and allowing for 
increased levels of protein expression and subsequently favoring cellular Fe internalization 
(Muckenthaler et al., 2017). On the other hand, IRP-1 and IRP-2 bound to the sole IRE motif in 
the 5’ UTR region of Fth mRNA inhibit its translation by preventing ribosome attachment 
(Hentze et al., 2010; Arosio et al., 2017). This antithetical effect allows for Fe uptake by TFR-1 
when cellular Fe concentration is low while concurrently inhibiting ferritin production (Wilkinson 
and Pantopoulos, 2014) (Figure 1.4). The reverse happens when cellular Fe concentration is high, 
as the cell shuts down Fe import by inhibiting TFR-1 while increasing cellular Fe storage 
(Muckenthaler et al., 2017). 
The majority of bioavailable Fe is contained in the form of heme, the prosthetic group 
contained in hemoglobin, myoglobin and cytochromes as well as other hemoproteins (Gozzelino 
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et al., 2010) (Figure 1.5). About 20-25 mg of Fe is needed by the bone marrow per day for the de 
novo synthesis of the heme required to generate hemoglobin (Ganz, 2012) (Figure 1.5). By 
contrast, Fe uptake from diet only accounts for 1-2 mg on a daily basis (Gozzelino and Soares, 
2014). In adult humans, around 200 billion of RBCs are produced each day which requires an 
extraordinary 2x1015 Fe atoms to be used per second (Muckenthaler et al., 2017). Each erythrocyte 
contains approximately 1.2×109 of heme molecules associated with hemoglobin, and 
approximately 200 billion erythrocytes become senescent every day (Muckenthaler et al., 2017).  
 
 Damaged or aged erythrocytes can leak hemoglobin into the circulation, which upon loss 
of conformational stability, release their heme moiety potentiating generation of lipid peroxides, 
damage to DNA and oxidative damage of proteins (Alkhateeb and Connor, 2013). Additionally, 
Fe released from heme can further generate deleterious free radicals via the Fenton reaction (Nairz 
et al., 2017). Just a small release of the potentially cytotoxic labile Fe contained in hemoglobin 
can generate extensive damage and argues for the necessity of tightly controlled regulatory 
mechanisms that efficiently recycle and distribute Fe throughout the organism (Soares and 
Hamza, 2016). 
 
Figure 1.4 IRP/IRE machinery controls intracellular Fe responses. In response to low iron levels, 
IRP-1 and IRP-2 become activated and are able to bind to IRE sequences in the 5’ and 3’ end of FTH 
and Transferrin Receptor (TfR) respectively which inhibits translation of both ferritin subunits while 
promoting iron uptake by increasing TfR mRNA stability and subsequent translation. In an excessive 
intracellular environment IRP-1 forms an iron sulfur cluster and acts like a cytosolic aconitase (c-
acon) redering it unable to interact with IREs while IRP-2 is degraded making it uncapable of binding 
to IREs, thus promoting iron storage by increasing ferritin mRNAs translation and inhibiting iron 
uptake by destabilizing TfR mRNA. Taken from (Torti and Torti, 2002). 
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In order to avoid widespread Fe-driven oxidative damage, several protective programs are in 
place. At steady state, damaged and senescent erythrocytes are detected by erythrophagocytic 
macrophage subsets which reside in the spleen, liver, and bone marrow. These erythrophagocytic 
macrophages that engulf and digest senescent or damaged erythrocytes, actively prevent the 
development of heme-Fe stress and damage. In the spleen, erythrophagocytosis is primarily 
achieved by Red-Pulp Macrophages (RPMs) which express scavenger receptors (Nairz et al., 
2017) allowing phagocytosis and internalization of the RBCs (Soares and Hamza, 2016). After 
internalization, heme is catabolized in the phagolysosome of RPMs and subsequently transported 
to the cytoplasm via the heme-responsive gene 1 (HRG-1) (Soares and Hamza, 2016). This leads 
to the accumulation of labile heme in the cytoplasm which results in the induction of heme 
oxygenase 1 (HO-1) expression 
(Gozzelino et al., 2010). This 
catabolizes heme , generating 
equimolar amounts of carbon 
monoxide (CO), biliverdin and 
Fe2+ (Gozzelino et al., 2010). 
Then, depending on the systemic 
Fe equilibrium, the released Fe2+ 
can be either stored inside the 
cell by incorporation into ferritin 
or exported via FPN-1 (Frazer 
and Anderson, 2014). Once 
exported, Fe binds TF to form 
TF-Fe complexes (Nairz et al., 
2017), which can be further 
utilized for de novo hemoglobin 
synthesis by erythroblasts during 
erythrocyte development. 
Differentiation of RPMs in the spleen is dependent on the expression of the transcription factor 
SPI-C (Kierdorf et al., 2016), as the deletion of SPI-C prevents the generation of RPMs and alters 
the formation of the red pulp in the spleen (Kohyama et al., 2009; Nairz et al., 2017). Furthermore, 
heme leads to the induction of SPI-C (Haldar et al., 2014) via the binding to a repressor called 
Btb and Cnc Homology 1 (BACH-1) that constitutively inhibits SPI-C expression (Haldar et al., 
2014). Binding of heme to BACH1 triggers its degradation allowing for expression of SPI-C and 
differentiation of RPMs (Kurotaki et al., 2015). Although it remains unknown whether this 
pathway is active during fetal development of macrophages, hemolytic diseases leading to splenic 
heme overload drive the expression of SPI-C in circulating monocytes that then migrate to the 
 
Figure 1.5. Bioavailable Fe in mammals. Considering the 
totality of bioavailable Fe in mammals, only 20-25% is 
associated with Fe binding proteins, the rest is associated with 
heme-containing molecules such as hemoglobin, myoglobin and 
cytochromes which are the main hemoprotein compartments in 
mammals. Hemoglobin is abundantly present in red blood cells 
(RBCs), myoglobin in muscle cells and cytochromes in the 
majority of other cells. Distribution inside each of these 
compartments is also considerably unequal since 70% of this 
heme is contained in hemoglobin while the remaining 20-25% 
and 5-10% are contained in cytochromes and myoglobin 
respectively. Fe can transit from heme to non-heme or 
conversely through de novo heme catabolism or biosynthesis. 




spleen and help prevent heme-Fe-related cytotoxicity by providing a functional support to RPMs 
(Haldar et al., 2014). A very similar mechanism has been described whereby heme-Fe 
accumulation in the liver drives the differentiation of circulating monocytes into a functional Fe-
recycling macrophage subset that expresses high levels of FPN (Theurl et al., 2016). Similarly, 
acute kidney failure induced by accumulation of myoglobin after muscle injury, drives the 
recruitment and differentiation of macrophages which then can activate the expression of HO-1 
(encoded by Hmox1) as well as the expression of CD163 and ferritin to detoxify heme-Fe (Nairz 
et al., 2017). Macrophages also play an important role in Fe clearance in the heart, an organ known 
to be extremely sensitive to Fe-induced toxicity due to the lack of regenerative potential of the 
myocardium (Nairz et al., 2017). In fact, these cell types have been shown to provide Fe for the 
myocardium and detoxify heme-Fe 
preventing tissue injury (Nahrendorf and 
Swirski, 2016). Moreover, a recent study 
showed that the recruitment of 
macrophages to sites of muscle damage 
is essential to promote muscle tissue 
regeneration while preventing Fe-
associated cytotoxicity (Corna et al., 
2016). After acute muscle injury and 
release of myoglobin, muscle-
infiltrating macrophages not only take 
up Fe to prevent tissue damage but also 
promote regeneration and proliferation 
of muscle stem cells through a 
mechanism involving FPN-mediated Fe 
export (Corna et al., 2016). Finally, 
macrophages developed several 
mechanisms that enable them to clear or 
resolve Fe overload and return to steady-
state conditions. One such strategy is 
through the incorporation of Fe in 
ferritin which can act as a mechanism to 
detoxify Fe mediated cytotoxicity and 
prevent tissue Fe overload (Theil, 2013; 
Nairz et al., 2017). Interestingly, 
macrophages express high levels of 
ferritin that is secreted into plasma 
 
Figure 1.6. Salutary effects of ferritin in the overall 
reduction of reactive oxygen species. Disruptions in 
Fe homeostasis caused by hemolysis, infection or 
inflammatory cues such as release of Tumor Necrosis 
Factor (TNF) by macrophages cause an overall increase 
in intracellular reactive oxygen species (ROS) levels. 
TNF (internalized by the TNF receptor, TNFR) can 
directly generate ROS while heme can act directly or 
indirectly after release of Fe by increasing the labile Fe 
pool. The synergistic effect of these molecules leads to 
constant high concentrations of ROS that sustain the 
activation of c-Jun N-terminal kinase (JNK) signaling 
transduction pathway that inhibits FTH synthesis and 
leads to the activation of Caspase 3 which culminates 
in programed cell death (PCD). The ferroxidase activity 
of FTH counteracts the accumulation of ROS by 
retaining Fe in a non-reactive form thus preventing 
potential intracellular labile Fe accumulation, which 
ultimately prevents cell death. Adapted from 
(Gozzelino et al., 2012). 
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(Cohen et al., 2010). The secreted ferritin can act as an Fe source for erythroid progenitor cells 
(Leimberg et al., 2008), suggesting that macrophage-derived ferritin functions as vehicle for Fe 
transport/transit (Leimberg et al., 2008) providing Fe to tissues in a non-cytotoxic form. 
In animals, ferritin is composed of a highly conserved ferritin Heavy chain (FTH) and ferritin 
Light chain (FTL). The two proteins self-assemble and organize into a multimeric complex of 24 
subunits, giving rise to a 480 kDa hollow sphere (Arosio et al., 2017). This complex is capable of 
storing up to 4500 atoms of Fe3+ (Arosio et al., 2015), an effect that relies on the ferroxidase 
activity of FTH, which converts highly reactive Fe2+ into Fe3+ thereby inhibiting the production 
of free radicals via the Fenton reaction (Gozzelino and Soares, 2014; Arosio et al., 2015). The 
FTL subunit does not possess ferroxidase activity, and is instead responsible for the formation of 
the Fe core inside the protein shell (Arosio et al., 2017). 
Ferritin expression is regulated by several molecular pathways which act both at the 
transcriptional and post-transcriptional level (Theil, 2013; Wilkinson and Pantopoulos, 2014). 
Transcriptional regulation occurs mainly through the activation of nuclear factor kappa B (NF-
kB) and the transcription of nuclear factor E2-related factor-2 (NRF2) (Gozzelino and Soares, 
2014) as well as BACH1-1 which is a transcriptional regulator of the macrophage lineage (Soares 
and Hamza, 2016). As mentioned above, ferritin regulation also occurs post-transcriptionally via 
the IRP/IRE machinery, allowing for quick and efficient responses up-regulating ferritin when Fe 
levels are high and inhibiting its expression when Fe levels are low (Torti and Torti, 2002). 
These observations have placed ferritin regulation not only in the context of Fe homeostasis 
but also in the broader framework of cell injury, oxidative stress and inflammation (Torti and 
Torti, 2002) (Figure 1.7). The imbalances and disruptions that occur in cellular Fe and ferritin 
levels are emerging as an important element in the pathogenesis of several diseases (Theil, 2013; 
Papanikolaou and Pantopoulos, 2017). Interestingly, while mutations in the FTL subunit can lead 
to a wide range of Fe related pathologies (Finazzi and Arosio, 2014) no mutations in the coding 
sequence of Fth are known, arguing for the incompatibility of life in the absence of this protein 
(Finazzi and Arosio, 2014). Deletion of the Fth allele is embryonic lethal in mice whereas the 
sole expression of FTL is unable to maintain Fe in a non-toxic form and compensate for the 
absence of FTH (Ferreira et al., 2000). Additionally, conditional deletion of Fth leads to the loss 
of intracellular Fe storage capacity and to tissue damage in the liver (Darshan et al., 2009) while 
Fth deletion in tubular kidney cells leads to renal inflammation through the influx and 




Outline of the master project 
Given that deletion of Fth allele is embryonically lethal in mice the host laboratory developed a 
mouse strain that allows for regulated Fth allele deletion in adult animals. Unexpectedly, Fth 
deletion led to multi-organ dysfunction and death. This outcome was avoided when Fth-deleted 
mice were transplanted with wild-type bone marrows (See the “Results” section), an effect that 
relies on the expression of Fth in the monocytic lineage. My research project focused on 
addressing three main questions. First, what is the contribution of FTH expression by 
macrophages to FTH expression by parenchyma tissues? Second, what macrophage population is 
involved in maintenance of Fe homeostasis via the expression of FTH? Third, can macrophages 
deliver FTH directly to parenchyma tissues? The data obtained suggest that: i) FTH expression 
by macrophages contributes critically to the overall expression of FTH in parenchyma tissues, ii) 
Bone marrow derived Ccr2+ macrophages are likely involved in maintenance of Fe homeostasis 





2. Materials and Methods 
2.1. Mice 
The following mouse strains developed in the host laboratory were used for this Master thesis project: 
Table 2.1. Experimental organisms used in this thesis, along with their original sources and references. 
Organism/Strain Reference Source 
C57BL/6J Charles River Laboratories N/A 
B6. Fthlox/lox (Darshan et al., 2009) 
Prof. Lukas Kuhn, ETH, 
Switzerland 
B6.ROSA26Cre-ERT2 (Vooijs et al., 2001) JAX stock 008463 
B6.ROSA26Cre-ERT2 Fthlox/lox (Weis, Carlos et al., 2017) IGC  




B6.CCR2-/- (Boring et al., 1997) JAX stock 004999 
B6.V5-Fth Unpublished IGC 
 
Every procedure involving animals was performed in compliance with institutional and national 
guidelines. All animal protocols used were approved by the Instituto Gulbenkian de Ciência ethical 
committee and the ‘‘Órgão Responsável pelo Bem-estar dos Animais (ORBEA)’’ and consequently 
licenced by the Direccão Geral de Alimentação e Veterinária (DGAV). All animal experiments follow 
the Portuguese (Portaria nº 1005/92, Decreto-Lei nº 113/2013) and European (Directive 2010/63/EU) 
legislations, concerning housing, husbandry and animal welfare. 
2.1.1. Allele deletion 
Deletion of floxed alleles by Cre recombinase activation was achieved by Tamoxifen administration 
(Sigma-Aldrich Ref: T5648-5G). For deletion of R26CreER-T2Fthlox/lox mice a stock solution of 45mg/mL 
of Tamoxifen in 5% EtOH/Corn oil was prepared and sonicated for 5min (60W). For the deletion of 
bone marrow chimeric mice a stock solution of 10mg/mL of Tamoxifen in 5% EtOH/Corn oil was 
prepared, sonicated for 5 min (60W), and vortexed (1 min) and 100L Tamoxifen solution (1mg) was 
administered by oral gavage 3 times every other day. For deletion of CX3CR1
CreER-EYFPR26DsRedfl/flFthlox/lox 
(henceforth referred as Cx3cr1CreER-T2Fthlox/lox) mice, Tamoxifen was administered by oral gavage 9 
times, twice a week, or alternatively using Tamoxifen enriched diet (360 mg/kg Tamoxifen citrate Ssniff 




2.2. Bone marrow chimeric mice 
2.2.1. Irradiation 
Recipient mice were lethally irradiated (750 rads) by exposure to a Cesium radioactive source (3 min) 
in a Gamma Cell 2000 irradiator (Molsgaard Medical Serial Number: 86/4/14). 
2.2.2. Bone marrow extraction and cell isolation 
Bone marrow donor mice were sacrificed by CO2 narcosis until a complete heart arrest was reached. 
The tibia and femur bones were isolated and placed in ice cold RPMI 1640 Medium, GlutaMAX 
supplement (Thermo Fisher Ref: 61870-010). Bones were cut and the bone marrow was flushed using 
a 10 mL syringe (Terumo Ref: SS+10ES1) with a 0,5x16 mm 25G x 5/8 disposable needle (Poulten 
John LTD Ref: 7.510-02). Cells were washed two times in RPMI at (Eppendorf Centrifuge 5810R) (4ºC 
10 min, 300 g). Cells were re-suspended in 10 mL RPMI and subsequently passed through 100 m cell 
strainers (BD Biosciences Ref: 352360). Cell number was quantified in a hemocytometer with a Trypan 
Blue solution (Sigma Ref: T8154). After quantification, cells were centrifuged again at 4ºC for 10 mins 
at 300 g and subsequently re-suspended in an adequate volume of PBS required for a cell suspension of 
2.5x107 /mL. 
 
2.2.3. Bone marrow chimeric mice 
After quantification, cells were re-suspended in Phosphate-Buffered Saline (PBS) (2.5x107 cells mL-1). 
5x106 hematopoietic cells were intravenously injected in the tail of lethally irradiated recipient mice. 
Cells were allowed to engraft the recipient mice bone marrow and immune cell reconstitution was 
analyzed in blood by flow cytometry after 8 weeks. An irradiation control mouse was used that did not 











2.2.4. Bone marrow reconstitution check by Flow Cytometry 
8 weeks after bone marrow reconstitution, blood was collected from the tail and placed in (PBS). The 
cells were pelleted after centrifugation at 4ºC (Eppendorf Centrifuge 5810R) for 5 min, 300 g. 
Supernatant was discarded followed by incubation with erythrocyte lysis buffer (5 min) to lyse red blood 
cells (90% 160 mM 
Ammonium Chloride; 10% 100 
mM Tris-HCl). Between each 
incubation step the cells were 
washed with PBS. Afterwards, 
the cells were stained with Fc 
Block (ref) for 15 min at 4ºC 
and labeled with lineage 
specific Abs (see 2.2.5 Abs for 
flow cytometry) for 30 min at 
4ºC in the dark. Non-bound 
Abs were washed and the cells 
re-suspended in PBS.  
2.2.5. Abs for flow cytometry 
Cells were labeled according to cell surface lineage markers that allowed identification of distinct cell 
types. For identification of B cells, they were labeled with anti-CD19 Ab conjugated with the 
fluorophore PECy7, for T cells the labelling was done with anti- TCR-b Ab conjugated with Bv421 
fluorophore, for monocytes identification was achieved by labeling with anti-CD11b Ab conjugated 
with PerCpCy5.5 fluorophore and for neutrophils the staining was performed with both anti-CD11b 
conjugated with PerCpCy5.5 and Ly-6G/Gr1 conjugated with PE Abs. All Abs used were kept at 4º C 








Figure 2.1. Schematic representation of the generation of bone 
marrow chimeric mice. Radiation was performed with 750 rad. Mice 
were left to recover for 8 weeks to allow for full reconstitution of the host 
immune system. Taken and adapted from (Ravikumar et al., 2014).  
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Table 2.2. Abs used for flow cytometry experiments, along with the sources and references. 





















Rat IgG2a, κ BDBiosciences 551461 
 
2.2.6. Cell staining acquisition  
Flow cytometry acquisition was performed immediately after reconstitution check and acquired in 
Fortessa X20 (BD Biosciences). 10,000 cells were counted per sample and the data was analyzed on 
FlowJo VX (Tree Star Inc, Country). 
2.3. Genotyping 
2.3.1. Deoxyribonucleic acid (DNA) extraction 
A piece of tail from each mouse was extracted and placed in individual Eppendorf tubes. Fresh KAPA 
Mouse Genotyping Kit extraction enzyme and extraction buffer (Kapa Biosystems Ref: KK7352), and 
ultrapure water was added to each tube in the following amounts (1x volume for a total volume of 50 
L/tube): 1 L Extraction enzyme, 5 L Extraction buffer, 44 L ultrapure water. Samples were 
incubated at 75ºC in a hot plate for 15 min and afterwards at 95ºC for 5 min. Samples were quickly 
vortexed for 5 seconds and centrifuged for 1 min at room temperature in an Eppendorf Centrifuge 
5415D. From this point, samples can be stored at -20ºC or -80ºC for optimal preservation of the extracted 
DNA. 
 
2.3.2. Polymerase Chain Reaction (PCR) 
For the PCR reaction the extracted DNA was added to a master mix prepared from KAPA Mouse 
Genotyping Kit (Kapa Biosystems Ref: KK7352) by combining the following components. (1x volume 
for a total volume of 10 L/tube):  5 L 2x KAPA 2G Fast genotyping mix; 0,5 L Forward primer; 0,5 
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L Reverse primer; 3 L ultrapure water; 1 L DNA sample. All PCR reactions were performed using 
a MyCycler™ Thermal Cycler System (BIO-RAD Ref: 1709703) using the following program:  
 95ºC – 5 min 
 95ºC – 15 seconds 
 Tm – 15 seconds 35 cycles 
 72ºC – 20 seconds 
 72ºC – 5 min 
 4ºC – 60 min 
 
Different annealing temperatures (Tm) were used depending on the specific screening. The different 
primers are indicated in Table 2.3. 
 
Table 2.3. PCR primers used and experimental conditions. Fwd stands for Forward primer and Rev stands 
for Reverse primer.  











2.3.3. Gel electrophoresis 
Electrophoresis 1.5% agarose gel was prepared using the following components (for 150mL of total 
volume): 
 Agarose (Lonza Verviers Ref: 50004) - 2,25 gr 
 (Tris-Acetate) TAE buffer 1x (40 mM Tris, 20 mM acetic acid and 1 mM EDTA) - 150 mL 
 RedSafe Nucleic Acid Staining Solution (INTRON Ref: 21141) - 15 L 
 
Agarose and TAE buffer were mixed and heated on a normal kitchen microwave for 3 min until boiling. 
After the agarose completely dissolved the RedSafe Nucleic Acid Staining Solution was added in the 
previous indicated amount. The gel was allowed to solidify for 30 min at room temperature. PCR 
products were added to each well alongside a Gene Ruler 100bp DNA Ladder (Thermo Scientific Ref: 
SM0241). Electrophoresis was performed in a Sub-Cell® GT Agarose Gel Electrophoresis Systems 
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(BIO-RAD) gel chamber filled with 1x TAE buffer at a constant voltage of 80-100V for 30-60 min. 
Results were analyzed by UV radiation in a Gel Doc EZ Imager (BIO-RAD Ref: 170-8270). 
 
2.3.4. Polyacrylamide Gel Electrophoresis (PAGE) 
After regular PCR protocol (described in 2.3.2) a PAGE gel was prepared using the following 
components (for 15 mL of total volume): 
 Ultrapure water – 5,85 mL 
 30% Polyacrylamide (BIO-RAD Ref: 161-0156) – 7,5 mL 
 Tris-Borate-EDTA (TBE buffer) 1x (220 mM Tris, 180 mM boric acid, and 5 mM EDTA) 
 10% Ammonium Persulfate (APS) (BIO-RAD Ref: 1610700) – 0,15 mL 
 Tetramethylethylenediamine (TEMED) (Sigma-Aldrich Ref:T9281) – 0,009 mL 
 
After addition of APS and TEMED, which start the polymerization process, the mixed solution was 
quickly added to 0.75 mm Spacer Plates for WB (BIO-RAD Ref: 1654111) and 10 well combs (BIO-
RAD Ref: 1653308) were carefully placed. The gel was allowed 30 min to polymerize. After 
polymerization the comb was removed and the gel setup was then placed in the electrophoresis unit 
(BIO-RAD). 1x TBE buffer was used to fill the inner chamber, some volume was also added to the outer 
chamber. PCR products were added to each well alongside a Gene Ruler 100bp DNA Ladder (Thermo 
Scientific Ref: SM0241) and the gel ran for 3 h at 150V.  
After electrophoresis, the separating gel was removed from its encasing cassette and placed in 25 mL 
TBE buffer with 25 L of RedSafe Nucleic Acid Staining Solution (INTRON Ref: 21141) for 1 h. After 
 
Figure 2.2. Representative scheme for amplification strategies for Fth and V5 identification. A) 
Screening of Fth allele in a wild type mouse using Fth Forward and Fth Reverse primers. The amplicon is 
expected to have 233 base pairs (bp). B) Screening of a modified Fth allele with a V5 tag sequence of 42 bp 
in the N-terminus. Accordingly, the amplified segment is expected to have 275 base pairs. C) Screening of a 
modified Fth allele with a V5 tag using V5 Forward and Fth Reverse primers. The amplicon produced in this 
screening should have 167 bp. 
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incubation the gel was carefully removed and the results were analyzed by UV radiation in a Gel Doc 
EZ Imager (BIO-RAD Ref: 170-8270). 
2.4. Western Blot 
2.4.1. Protein extraction from tissues 
Mice were sacrificed by CO2 narcosis until complete heart arrest. After death, mice were perfused by 
intracardiac injection with 20 mL of cold PBS to remove the blood out of the vasculature. Organs were 
collected in 1.5 mL Eppendorf tubes and snap frozen in liquid nitrogen. From this point samples can be 
stored at -80ºC to avoid protein degradation. Proteins were extracted from tissues by mechanic 
disruption of tissues in RIPA buffer (50 mM Tris-HCl ph=7.5; 150 mM NaCl; 1 mM EGTA; 1 mM 
Sodium Orthovanadate; 1 mM Sodium Fluoride; 1% NP40) containing a complete, EDTA Free Protease 
Inhibitor tablet (Roche Ref: 11 873 580 001) using a 2 mL Dounce Tissue Grinder Set (Sigma-Aldrich 
Ref: D8938). The mixture was then transferred into new 1.5 mL Eppendorf tubes and incubated for 20 
min on ice. Disrupted tissues were then sonicated for 20 secs at 300W in the Ultrasonic Processor XL 
2020 Sonicator (Misonix, Inc). The sonicated samples were spin down at 13700 g at 4ºC (Eppendorf 
Centrifuge 5417R). Finally, supernatants, containing proteins, were transferred to fresh Eppendorf tubes 
and stored at -20ºC for further quantification and western blot analysis. 
2.4.2. Protein Quantification by the Bradford Assay 
To quantify the amount of proteins obtained after tissue disruption we used the Bradford assay 
(Bradford, 1976). The Bradford reagent (BIO-RAD Ref: 500-0006) was first diluted in ultrapure water 
according to manufacturer guidelines. Due to high protein concentrations our protein mixture was 
diluted in RIPA buffer and 1 L of the mixture was added to 1 mL of the Bradford solution and incubated 
at room temperature during 20-30 min in the dark. Serial dilutions of Purified Bovine Serum Albumin 
(New England Biolabs Ref: B9001S) were also prepared and used as our standard and 1 L of each 
dilution was added to the Bradford solution and incubated for 20-30 min in the dark. Sample Absorbance 
was detected by spectrophotometry, measuring the wavelengths at 595 nanometers (nm) in a 
SmartSpec™ 3000 Spectrophotometer (BIO-RAD). RIPA buffer diluted in the Bradford solution was 
used as blank to zero the spectrophotometer. To create a standard curve, we plotted the 595 nm values 
of BSA (y-axis) versus their concentration in µg/ml (x-axis). We used the standard curve and multiplied 
by the dilution factor to determine the protein concentration of our samples.  
2.4.3. Protein electrophoresis 
Protein extracts were equally adjusted to 80 g per sample in Laemmli Sample Buffer (BIO-RAD Ref: 
161-0737) and denatured for 15-20 min at 70ºC. Given the small molecular weight of the proteins 
analyzed (between 21 kDa to 42 kDa) by western blot, 12% polyacrylamide gels were chosen which 
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allow for optimal separation in a range between 10-100 kDa. The reagents used for both Separating and 
Stacking gels are shown below: 
Separating gel (for 10 mL total volume): 
 Ultrapure water – 3.3 mL 
 30% Polyacrylamide (BIO-RAD Ref: 161-0156) – 4 mL 
 1M Tris (pH=6,8) – 2,5 mL 
 10% Sodium n-Dodecyl Sulfate (SDS) (MerckMillipore Ref: 428018) – 0,1 mL 
 10% Ammonium Persulfate (APS) (BIO-RAD Ref: 1610700) – 0,1 mL 
 Tetramethylethylenediamine (TEMED) (Sigma-Aldrich Ref:T9281) – 0,004 mL 
 
After addition of APS and TEMED, which start the polymerization process, the mixed solution was 
quickly added to 0.75 mm Spacer Plates for WB (BIO-RAD Ref: 1654111) or 1.5 mm Spacer Plates for 
WB (BIO-RAD Ref: 1653312) according to the number of samples and left to polymerize at room 
temperature for 1 h.  After polymerization the process was repeated for the Stacking gel (for 3mL total 
volume): 
 Ultrapure water – 2,1 mL 
 30% Polyacrylamide (BIO-RAD Ref: 161-0156) – 0,5 mL 
 1M Tris (pH=6,8) – 0,38 mL 
 10% Sodium n-Dodecyl Sulfate (SDS) (MerckMillipore Ref: 428018) – 0,03 mL 
 10% Ammonium Persulfate (APS) (BIO-RAD Ref: 1610700) – 0,03 mL 
 Tetramethylethylenediamine (TEMED) (Sigma-Aldrich Ref: T9281) – 0,002 mL 
 
APS and TEMED were combined with the other reagents and the mixed solution was added on top of 
the polymerized Separating gel. 10 well combs (BIO-RAD Ref: 1653308) or 15 well combs (BIO-RAD 
Ref: 1653365) were carefully placed before polymerization according to the number of samples. After 
polymerization the comb was removed and the gel setup was then placed in the electrophoresis unit 
(BIO-RAD). 1x Running buffer solution was prepared from 10x Running buffer (248 mM 
Tris(hydroxymethyl)aminomethane; 1,92 mM Glycine; 1% SDS and 1L ultrapure water) and used to 
fill the inner chamber, some volume was also added to the outer chamber. Samples were loaded 
alongside NZYColour Protein Marker II (NZY Tech Ref: MB09002) and the gel ran for 30 min at 50V 
or until the proteins reach the beginning of the Separating gel. From this point, the voltage was increased 
to 100V and the gel ran for an additional 60 min.  
2.4.4. Immunobloting 
After protein electrophoresis, the separating gel was removed from its encasing cassette and placed in a 
Transfer buffer (48 mM Tris; 39 mM Glycine; 0,5% SDS; 1L ultrapure water). A polyvinyldifluoridine 
membrane (PVDF) (BIO-RAD Ref: 162-0177) was cut with the same area as the gel, activated with 
100% methanol for 1 min, washed with ultrapure water and placed in Transfer buffer for 5 min. The 
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blot was setup accordingly to the scheme presented in figure 2.3 using Extra-Thick Paper Filters (BIO-
RAD Ref: 1703966). Proteins were transferred onto the PVDF by semi-dry transfer electroblotting 
performed using a Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell (BIO-RAD Ref: 170-3940) 
such as the one depicted in figure 2.3. The transfer ran for 20 min at 12V. After transfer, the membrane 
was blocked for 60 min in blocking buffer (5% Non-Fat Dry Milk powder in PBS; 0,1% TWEEN-20) 
and incubated overnight at 4ºC on a rocking platform with primary Abs (see Abs for western blot). The 
next day, the membrane was then washed three times with Tris-Buffered Saline Tween-20 (TBST) (pH= 
7,5; 20 mM Tris; 150 mM NaCl; 0,1% Tween-20) for 15 min and incubated with secondary Abs 
conjugated with Horseradish Peroxidase (HRP) for 60 min at room temperature (see 2.3.5 Abs for 
western blot). After a repetition of the washing step for 15 min the membrane was ready for detection 
of the chemiluminescent substrate. 
Detection was achieved by Pierce 
ECL Western Blotting Substrate 
(ThermoFisher Ref: 32209) or 
SuperSignal West Pico 
Chemiluminescent Substrate 
(ThermoFisher Ref: 34080) 
according to signal intensity. In 
our experiments, we used the 
same membrane to stain for FTH, 
V5, B-Actin and GAPDH. FTH 
and V5 proteins have very similar 
molecular weights (differing in 
approximately 1.5 kDa). To 
accurately distinguish between 
stainings and to remove previous 
background staining or non-
specific binding, subsequent membrane stripping was needed. Membranes were incubated two times 
with Stripping Buffer (200 mM Glycine; 3,5 mM SDS; 1% Tween-20 in 1L ultrapure water) for 10 min 
each at room temperature and extensively washed in PBS (two times, 10 min at room temperature under 
soft agitation). Subsequent washings with TBST were also performed (two times, 5 min at room 
temperature under soft agitation). Thereafter the membrane was blocked with 5% non-fat dry milk 
powder in TBST for 1h at room temperature ready to use for protein staining. 
 
 
Figure 2.3. Schematic representation of the stack setup for transfer 
of proteins from the acrylamide gel to the PVDF membrane using 
a Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell. 
Electrical current flows from the negatively charged cathode plate to 
the positively charged base allowing for a continuous and homogenous 
current to travel along the gel to the PVDF membrane.  
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2.4.5. Abs for western blot 
Incubation with primary Abs occurred overnight at 4ºC with primary Abs directed against Ferritin Heavy 
Chain, V5 epitope, B-Actin and GAPDH. Peroxidase conjugated secondary Abs were used for signal 
detection. Full list of Ab specifications is presented in Table 2.4. 
Table 2.4. Abs used for western blot experiments with the isotype, dilution, source and reference. 
Ab Isotype Dilution Source Reference 
Anti-FTH 
(monoclonal) 
Rabbit IgG 1:1000 Cell Signaling 4393 
Anti-V5 
(monoclonal) 
Mouse IgG2a 1:5000 Invitrogen R96025 
Anti-V5 
(polyclonal) 
Goat N/A 1:5000 Abcam AB9137 
Anti-GAPDH 
(polyclonal) 
Goat N/A 1:5000 SICGEN AB0049-200 
Anti-b-actin 
(monoclonal) 
























2.5.1. Immunostaining in paraffin sections 
Mice were sacrificed by CO2 narcosis until a complete heart arrest was reached. After death, mice were 
perfused by intracardiac injection with 20mL of PBS to remove the blood out of the vasculature. The 
organs were collected and stored in 10% formalin, embedded in paraffin and cut into 3m cross sections 
by the IGC histopathology department. After deparaffinization slides were placed in Sodium Citrate 
Buffer (10 mM Sodium Citrate, 0.05% Tween 20, 1 L ultrapure water, pH=6.0) and heated for 2 min at 
750W in the microwave, and 4 min at 150W. The slides were then left to cool at room temperature and 
permeabilized with 0, 3% Triton/PBS for 15 min. Slides were blocked with commercial Goat serum 
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(Rockland Ref: D104-00-0050) for 60 min at room temperature and incubated with primary Abs (see 
3.4.2 Abs for immunofluorescence) overnight at 4ºC in a dark wet chamber. After 3 times washing with 
TBST (5 min each), tissue sections were incubated with fluorophore labeled secondary Abs (see 2.5.2 
Abs for immunofluorescence in paraffin sections) for 2 h at room temperature in a dark wet chamber. 
Afterwards, slides were washed with TBST again and then with PBS for 10 min and mounted with 
Mowiol Mounting Medium (Sigma-Aldrich Ref: M1289-10ML) with 10 g /mL of 4',6-diamidino-2-
phenylindole (DAPI). Mounted slides can be directly utilized for microscopy or stored in the dark at -
20ºC to avoid photobleaching and allow for optimal fluorophore preservation. Images were acquired by 
fluorescence microscopy (see 2.6 imaging). 
 
2.5.2. Abs for immunofluorescence in paraffin sections 
For the immunofluorescence protocol in paraffin sections, detection of FTH, V5 and F4/80 was achieved 
with rabbit mAb directed against FTH, mouse mAb directed against V5 and rat mAb directed against 
F4/80. Slides were quickly washed and incubated with secondary Abs Alexa 647 Goat anti-Rabbit, 
Alexa 568 Goat anti-Mouse and Alexa 647 Goat anti-Rat for FTH, V5 and F4/80 detection respectively. 
Full list of Ab specifications is presented in Table 2.5. 
Table 2.5. Abs used for immunofluorescence in paraffin sections with the isotype, source and references. 
Ab Isotype Dilution Source Reference 
Anti-FTH 
(monoclonal) 
Rabbit IgG 1:100 Cell Signalling 4393 
Anti-V5 
(monoclonal) 
Mouse IgG 1:100 Invitrogen R96025 
Anti-F4/80 
(monoclonal) 














Goat IgG 1:500 ThermoFisher A-11077 
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2.5.3. Immunostaining in Whole-mount sections 
Immediately after sacrifice, an intracardiac injection of 20 mL of PBS was administered to perfuse the 
blood out of the vasculature. Subsequently, an additional intracardiac injection of 10 mL of 4% 
paraformaldehyde (PFA) prepared from a stock solution of 16% PFA (Alfa Aesar Ref: 043368-9M) was 
administered for fixation of the tissues and vasculature. Furthermore, the organs were excised and placed 
in a 4% PFA solution in a rolling platform overnight. Following the fixation, the organs were left to 
wash overnight with PBS at 4ºC. After washing the organs were fixed in a 12 well plate with 4% low-
melting point agarose solution (Invitrogen Ref: 15517-014) for 2 h. 100 m sections were obtained with 
a Leica Vibratome VT 1000 S (Leica Biosystems) and placed in small eppendorfs with PBDO 
permeabilization solution (1% Bovine Serum Albumin; 1% DMSO; 0.6 % Triton X-100 in PBS) 
overnight at 4ºC. Afterwards, organs slices were incubated with primary Abs overnight at 4ºC (see 2.4.3 
Abs for immunofluorescence). The removal of non-binding Abs was achieved through further overnight 
washing with PBDO permeabilization solution at 4ºC. Tissues were then incubated with Cy5 
fluorophore conjugated donkey anti-goat secondary IgG overnight at 4ºC (see 2.4.4 Abs for 
immunostaining in Whole-mount sections). After additional washing with PBDO overnight at 4ºC, 
incubation with the remaining secondary Abs (see 2.5.4 Abs for immunostaining) was done overnight 
at 4ºC. Finally, following another day of washing with PBDO the slices were mounted with Mowiol 
mounting medium with 10 g/mL of DAPI. Mounted slides can be directly observed in the microscope 
or stored in the dark at -20ºC. Images were acquired by confocal microscopy (see 2.6 Imaging). 
2.5.4. Abs for immunostaining in Whole-mount sections 
For the immunofluorescence protocol in whole-mount sections, detection of FTH, V5, F4/80 and 
CD68 was achieved with rabbit mAb directed against FTH, goat polyclonal Ab against V5, rat mAb 
against F4/80 and rat mAb against CD68. Slides were quickly washed and to avoid binding to the 
remaining secondary Abs the fluorophore-conjugated secondary Ab Donkey anti-Goat Alexa 647 for 
V5 detection was incubated first. After washing, the remaining secondary Abs Alexa 568 Goat anti-
Rabbit and Alexa 568 Goat anti-Rat for FTH, F4/80 and CD68 detection respectively. Full list of Ab 






Table 2.6. Abs used for immunofluorescence in whole-mount sections with the isotype, source and 
references. 
Ab Isotype Dilution Source Reference 
Anti-FTH 
(monoclonal) 
Rabbit IgG 1:100 Cell Signalling 4393 
Anti-V5 
(polyclonal) 
Goat N/A 1:200 Abcam AB9137 
Anti-F4/80 
(monoclonal) 
Rat IgG2a, κ 1:50 BioLegend 123102 
Anti-CD68 
(monoclonal) 













Goat IgG 1:500 ThermoFisher A-11077 
 
2.6. Imaging  
The two different immunohistochemistry protocols used involved different types of microscopy and 
by extension, two different microscopes: 
 Paraffin sections were visualized by fluorescence microscopy using a commercial Leica High 
Content Screening microscope based on Leica DMI6000 equipped with a Hamamatsu Flash 
4.0 LT sCMOS camera, using a 20x non-oil immersion objective and 40x oil immersion 
objective. DAPI + GFP and filtersets were controlled with the Leica LAS X software. 
 Images from whole-mount sections were acquired on a commercial Leica SP5 confocal based 
on Leica DM6000 inverted microscope equipped with an Argon-ion laser (458, 476, 488, 514 
nm lines) + 561 nm and 633 nm lasers. DAPI + GFP and filtersets were controlled with the 





2.7. Statistical Analysis 
Statistical analysis was performed in GraphPad Prism v6. Nonparametric Mann-Whitney U test was 
used to assess statistical significance between two groups. Mean differences between groups were 
analyzed using One-way ANOVA test. Log-rank test was used when survival was assessed as an end-




3.1. FTH is required to maintain homeostasis and sustain survival in adulthood. 
FTH protects cells from oxidative agents such as Fe2+, O2 and H2O2 (Theil, 2013). Under 
pathological conditions, disruption of systemic Fe homeostasis is associated with alterations of 
Fth expression that may contribute to the progression of certain diseases (Arosio et al., 2017; 
Papanikolaou and Pantopoulos, 2017), such as Parkinson, Alzheimer, atherosclerosis, pulmonary 
inflammatory states and rheumatoid arthritis (Torti and Torti, 2002). This is also the case for 
immune mediated inflammatory diseases in which FTH appears to regulate inflammation and 
immunity to infection as well as metainflammation (Torti and Torti, 2002; Nairz et al., 2016; 
Weis et al., 2017). Conditional deletion of the Fth allele in mice promotes tissue damage (Darshan 
et al., 2009) and inflammation (Bolisetty et al., 2015) and is essential to support homeostasis in 
response to systemic infections (Gozzelino et al., 2012; Weis et al., 2017). Given the embryonic 
lethality of Fth knockout mice (Ferreira et al., 2000) a new system was needed to assess the role 
of FTH in a fully developed organism. Therefore, we made use of ROSA26Cre-ERT2 mice, which 
express the Cre recombinase fused to a modified Tamoxifen responsive estrogen receptor under 
the ubiquitous and strong promoter ROSA26 (henceforth referred to as R26). The R26 mice were 
crossed with Fthlox/lox mice to generate R26.Fthlox/lox mice where the Fth allele is flanked by two 
loxP sites (Figure 3.1A). Upon Tamoxifen administration, activation of the Cre recombinase 
excises the region of Fth allele flanked by the loxP sites, thus generating mutant alleles that 
suppress Fth expression (R26.FthΔ/Δ) (Figure 3.1B).  
 
Figure 3.1. Deletion of Fth by Tamoxifen administration. A) Schematic representation of the 
generation of Rosa26CreER-T2Fthlox/lox mice showing Cre fused with the Tamoxifen responsive estrogen 
receptor 2 (ER-T2) under control of the ubiquitously expressed Rosa26 (R26) promoter. The ferritin 
heavy chain (FTH) gene is flanked by LoxP sites represented as black triangles. Scheme depicting 
Tamoxifen administration for the deletion of Fth in this mouse model showing excision of the Fth allele 
and one LoxP site after Tamoxifen-induced Cre activation. Red arrows represent the time of Tamoxifen 
administration (4.5mg of Tamoxifen/mouse). Tamoxifen was administered by oral gavage 3 times in 
the course of one week. 
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Deletion of the Fth allele was performed in 8 week-old mice and assessed by real time PCR 
on several tissues showing complete deletion in all tissues analyzed (Figure 3.2A) except the heart 
that showed some residual Fth mRNA expression and more evidently in the brain, where 
approximately 30% of Fth mRNA expression was retained (Figure 3.2A). We also confirmed the 
FTH deletion at the protein level, by western blot (Figure 3.2B-E). Expression of Fth in the heart 
was reduced by 60 to 75% (Figure 3.2C) in R26.FthΔ/Δ mice, as compared to control Fthlox/lox mice 
receiving Tamoxifen. In the kidneys there was a general reduction of FTH protein level in 
R26.FthΔ/Δ vs. Fthlox/lox mice, although this was not significant due to the high variation observed 
between samples from Fth-deleted mice (Figure 3.2D). Of the four R26.Fth Δ/Δ mice used for Fth 
deletion, three were efficiently deleted, whereas one still displayed considerable Fth expression, 
comparable to control Fthlox/lox mice (Figure 3.2D). In contrast, Fth protein expression was 
virtually absent in the liver (Figure 3.2B) and lungs (Figure 3.2E) of R26.FthΔ/Δ vs. Fthlox/lox mice. 
Of note Fth expression in both organs displayed high variability at steady-state (Figure 3.2B, E).  
Having confirmed the ability to delete Fth both at the mRNA and the protein levels, 
characterization of these mice was pursued considering their ability to maintain a homeostatic 
 
Figure 3.2. Fth mRNA and protein levels after Tamoxifen induced deletion.  A) Representative real 
time PCR confirming deletion of the Fth gene after Tamoxifen administration in the liver, heart, kidney, 
lungs and brain of R26.FthΔ/Δ (n=6) and control Fthlox/lox mice (n=4), courtesy of Birte Blankenhaus. B-
E) FTH western blot from Fthlox/lox (n=4) and R26.FthΔ/Δ (n=4) mice showing a general decrease in FTH 
protein levels after Tamoxifen deletion. Relative expression was normalized to Gapdh control in the 
liver (B), heart (C), kidney (D) and lung (E). *P<0,05, **P<0,005. 
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range on several parameters such as body weight and temperature. One week after Fth deletion, 
R26.FthΔ/Δ animals exhibited a dramatic decrease in body weight (Figure 3.3A) and temperature 
(Figure 3.3B), ultimately leading to death within 16 days (Figure 3.3C). This demonstrates that 
Fth expression is essential for maintenance of homeostasis in adult mice.  
 
3.2. Macrophage-derived FTH is sufficient to maintain homeostasis. 
Previous studies using tissue-specific Cre recombinase-mediated deletion of the Fthlox/lox did not 
show impairment of survival (Darshan et al., 2009; Vanoaica et al., 2010; Gozzelino et al., 2012; 
Bolisetty et al., 2015, 2016; Weis et al., 2017). This suggested the existence of some unknown 
homeostatic compensatory mechanisms that may counteract the lack of Fth in parenchyma 
tissues. Interestingly, macrophages have been shown to play important roles in the maintenance 
of homeostasis in situations where Fe imbalances occur (Ward et al., 2011; Theurl et al., 2016; 
Nairz et al., 2017). In keeping with this notion, bone marrow-derived macrophages expressing 
the heme catabolizing enzyme HO-1 have been shown to prevent heme-related cytotoxicity when 
expression of HO-1 is absent in parenchyma tissues (Kovtunovych et al., 2014). We took 
advantage of our model to interrogate the functional contribution of hematopoietic versus non-
hematopoietic compartment in the maintenance of homeostasis and survival following Fth 
deletion. Given the capacity of hematopoietic cells to fully regenerate all circulating cells and 
repopulate tissues in a myeloablated recipient (McGrath et al., 2015), R26CreER-T2.Fthlox/lox and 
control Fthlox/lox mice were lethally irradiated and reconstituted with bone marrow from R26CreER-
T2.Fthlox/lox or Fthlox/lox mice (Figure 3.4A). As expected, control Fthlox/lox recipients reconstituted 
with Fthlox/lox bone marrow survived subsequent Tamoxifen administration, not associated with 
Fth deletion, i.e. Fthlox/loxFthlox/lox mice (Figure 3.4B). In contrast, R26CreER-T2Fthlox/lox recipients 
 
Figure 3.3. FTH is required to sustain survival in adulthood. Body weight (A), body temperature 
(B) and survival (C) curves of Fthlox/lox (n=7) and R26.Fth∆/∆ (n=12) mice after deletion by Tamoxifen 
showing sharp decreases in weight and temperature and ultimately death of R26.Fth∆/∆ mice after Fth 




reconstituted with R26CreER-T2Fthlox/lox bone marrow lost body weight and temperature 
(Figure 3.4C and D), succumbing within 20 days after Tamoxifen-induced deletion of the Fthlox/lox 
allele, R26.FthΔ/Δ R26.FthΔ/Δ mice (Figure 3.4B). Surprisingly, Fthlox/lox recipients reconstituted 
with Fthlox/lox bone marrow did not succumb to Tamoxifen-induced deletion of the Fthlox/lox allele 
in parenchyma tissues, i.e. Fthlox/lox R26.FthΔ/Δ mice (Figure 3.4B). 
Taking into account the role of macrophages and myeloid-derived cells in Fe homeostasis 
(Soares and Hamza, 2016), we hypothesized that the capacity of bone marrow derived cells to 
supplement for Fth deletion in parenchyma tissues was likely mediated by the expression of FTH 
in bone marrow-derived monocyte/macrophages. To test this hypothesis, we generated 
LysMCreFthΔ/Δ animals (Figure 3.4A) where expression of Cre recombinase under the control of 
the LysM promotor, driving Cre expression specifically in the myeloid lineage, more specifically 
in macrophages (Clausen B.E et al., 2001). Since this promoter is constitutively expressed, 
macrophages lack Fth expression from birth. Lethal-irradiated R26.Fthlox/lox recipients 
reconstituted with LysMCreFthΔ/Δ bone marrow loss body weight and temperature, succumbing 
within 40 days of Tamoxifen-induced deletion of the Fthlox/lox allele in parenchyma tissues 
(Figure 3.4C, D), with the remaining animals eventually succumbing after 80 days, i.e. 
LysMCreFthΔ/Δ R26.FthΔ/Δ mice (Figure 3.4B). 
 
Figure 3.4. Influence of Fth expression by hematopoietic cells in chimeric mice. A) Schematic 
representation of bone marrow chimeras generated by irradiation of Fthlox/lox and R26CreER-T2Fthlox/lox 
mice. “D” represents the bone marrow donor mice and “R” represents the bone marrow receptor mice 
after the irradiation. B) Survival of Fthlox/loxFthlox/lox (n=7), R26CreER-T2Fth∆/∆R26CreER-T2Fth∆/∆ 
(n=6), Fthlox/loxR26CreER-T2Fth∆/∆ (n=10), and LysMCreFth∆/∆R26CreER-T2Fth∆/∆ (n=9). Body weight 




Next, we asked to what extent monocytes/macrophages complement the lack of FTH in this 
context. For this purpose we isolated heart, kidney, lungs and liver from Fthlox/loxFthlox/lox, 
Fthlox/loxR26.FthΔ/Δ and LysMCreFthΔ/ΔR26.FthΔ/Δ chimeras and assessed the levels of FTH by 
western blot.  Fthlox/loxFthlox/lox mice exhibited normal levels of FTH expression in heart, kidney, 
lungs and liver (Figure 3.5A-D). Although Fthlox/loxR26.FthΔ/Δ mice also express FTH in these 
organs (Figure 3.5A-D), the levels of FTH expression were decreased (Figure 3.5A-D), as 
compared to control Fthlox/loxFthlox/lox mice (Figure 3.5A-D). In contrast, FTH protein levels 
were virtually absent in the liver, kidneys and lungs of LysMCreFthΔ/ΔR26.FthΔ/Δ mice, 
suggesting that the majority of the hematopoietic FTH is expressed by monocyte/macrophages 
(Figure 3.5A, C, D). However, FTH expression in the hearts of LysMCreFthΔ/ΔR26.FthΔ/Δ mice 
does not appear to be significantly different from FTH levels of Fthlox/loxR26.FthΔ/Δ mice 
(Figure 3.5B). Taken together, these data demonstrate that when FTH expression is decreased in 
parenchyma tissues, expression of FTH by macrophages is critical to complement this deficiency, 
sustaining homeostasis and ultimately life. 
 
 
Figure 3.5. Contribution to FTH parenchyma levels by the LysM compartment.  Western blot and 
quantification of FTH in liver (A), heart (B), kidney (C) and lungs (D) of Fthlox/loxFthlox/lox (n=4), 
Fthlox/loxR26CreER-T2Fth∆/∆ (n=4), and LysMCreFth∆/∆R26CreER-T2Fth∆/∆ (n=4) chimeric mice. FTH 
expression was normalized to GAPDH. Fthlox/loxFthlox/lox mice represents 100% expression of FTH 





3.3. Identification of specific macrophage populations involved in the rescue of 
Fth-deleted mice. 
The origin of macrophages in mammals is still a matter of debate. The actual paradigm 
stipulates that tissue-resident macrophages, which have specialized function in tissues arise 
during fetal development (Gomez Perdiguero et al., 2014) and need to express the chemokine 
receptor CX3CR1 to migrate and develop in specific fetal tissues (Varol et al., 2015). At adulthood 
two main mechanisms occur at steady-state to maintain the pool of these cells. The first one is 
self-renewal and is observed mainly in the heart, brain and kidney (Varol et al., 2015). However, 
as the host ages or is subjected to tissue injury, circulating monocytes can transdifferentiate into 
functional tissue-resident macrophages (Perdiguero and Geissmann, 2015). Having established 
that the expression of FTH by macrophages is essential to restore survival of R26.FthΔ/Δ mice 
(Figure 3.4B), the question arose if expression of FTH in either circulating monocytes or tissue 
resident macrophages was responsible for this phenomenon. We used for that purpose Ccr2 
deficient (Ccr2-/-) mice in which the absence of this chemokine receptor prevents monocyte 
migration from the bone marrow into parenchymal tissues (Boring et al., 1997; Varol et al., 2015). 
We assumed that bone marrow macrophages from Ccr2-/- presumably still express normal levels 
of ferritin that upon secretion could possibly sustain the survival of R26.FthΔ/Δ recipient mice 
reconstituted with Ccr2-/- bone marrow, i.e. Ccr2-/-R26.FthΔ/Δ mice. Upon deletion of the Fth 
allele (Figure 3.6A), Ccr2-/-R26.FthΔ/Δ mice gradually lost body weight (Figure 3.6C) and more 
evidently lost body temperature (Figure 3.6D), when compared to control Fthlox/loxFthlox/lox mice. 
Tamoxifen-induced Fth deletion in Ccr2-/-R26.FthΔ/Δ mice led to 80% death (Figure 3.6B). 
However, the kinetic of death was delayed, as compared to LysMCreFthΔ/ΔR26.FthΔ/Δ mice, what 
the majority of Ccr2-/-R26.FthΔ/Δ mice dying approximately 100 days after Fth deletion. 
This could be due to the presence of a monocyte subset that can still migrate into 
injured/stress tissues and support tissue function and life for a certain amount of time. 
Accordingly, a recent work showed the existence of splenic reservoir monocytes that can migrate 
to stressed and injured tissues independently of Ccr2 (Swirski et al., 2009). To test this hypothesis, 
lethally irradiated R26.FthΔ/Δ and control Fthlox/lox mice were reconstituted with wild-type bone 
marrow. Under the assumption that bone marrow derived cells can repopulate the spleen after 
irradiation, the subsequent removal of the spleen would eliminate this specific population of 
infiltrating monocytes and therefore wild type bone marrow would not be sufficient to rescue 
R26.FthΔ/Δ hosts in the absence of the spleen. 8 weeks after reconstitution, we performed a 
splenectomy, waited for the recovery of animals and induced deletion of R26.FthΔ/Δ by Tamoxifen 
administration. We then monitored the survival of these animals. For technical reasons the non-
splenectomized control Fthlox/loxR26.FthΔ/Δ mice died (Figure 3.7A), and as such, further 







Figure 3.7. Influence of splenectomy on Fth deletion in bone marrow chimeric mice. A) Survival 
of splenectomised Fthlox/loxFthlox/lox (n=5), Fthlox/loxR26.Fth∆/∆ (n=5) and non-splenectomized 
control Fthlox/loxR26.Fth∆/∆ (n=6), R26.Fth∆/∆R26.Fth∆/∆ (n=6) and LysMCreFth∆/∆R26.Fth∆/∆ 
(n=9) mice upon Fth deletion. Body weight and temperature after Fth deletion are presented in (B) and 
(C) respectively. “Spl.” indicates groups that were splenectomised before Tamoxifen administration. 
 
Figure 3.6. Impact of Ccr2 expression on the survival of Fth deleted mice. A) Tamoxifen regime 
administered to these mice by oral gavage, 3 times in the course of one week. B) Survival curve after 
Tamoxifen induced deletion of Fth in Ccr2-/-R26.Fth∆/∆ (n=8) and control Fth lox/loxFthlox/lox (n=4), 
Fthlox/loxR26.Fth∆/∆ (n=4) mice. C) Body weight and temperature (D) after deletion. Red arrows 




As Cx3cr1 expression is required for both recruitment and retention of tissue resident 
macrophages (Pittet et al., 2014), being highly expressed in tissue-resident myeloid cells 
(Geissmann et al., 2003; Yona et al., 2013), we investigated whether Fth expression in CX3CR1
+ 
cells  rescued the survival of R26.FthΔ/Δ mice. To test this hypothesis we generated chimeric mice 
in which Fth was deleted in an inducible manner in CX3CR1+ cells. However, due to the self-
renewable characteristics of CX3CR1+ macrophage populations, there is a constant generation of 
bone marrow derived CX3CR1+ cells that must be continuously exposed to Tamoxifen-induced 
deletion, requiring an adjustment of the Tamoxifen regimen.  Therefore we applied a prolonged 
Tamoxifen regimen in order to achieve a sustained deletion of Fth in the CX3CR1
+ population. 
Tamoxifen was given two times a week during 3 weeks, in contrast to the original Fth deletion 
protocol which involved 3 administrations in the span of a week (Figure. 3.1B). Constant 
Tamoxifen treatment and concomitant Fth deletion proved to be exceedingly severe and led to 
loss of body weight (Figure 3.8B) and temperature (Figure 3.8C), and death of 50% of the 
R26.FthΔ/Δ mice, which received wild-type bone marrow (Figure 3.8A). In order to circumvent 
this, we switched to Tamoxifen food, allowing for constant Tamoxifen exposure and Fth deletion. 
However, administration of Tamoxifen food also led to death of chimeric Fthlox/loxR26.FthΔ/Δ 
mice, which does not allow to assess the significance of Fth deletion in chimeric Cx3cr1Cre-
ERT2FthΔ/ΔR26.FthΔ/Δ mice (Figure 3.8D), which decreased body weight (Figure 3.8E) and 
temperature (Figure 3.8F). However, chimeric Fthlox/loxR26.FthΔ/Δ mice succumbed with 
different kinetics from Cx3cr1Cre-ERT2FthΔ/ΔR26.FthΔ/Δ mice, with most Fthlox/loxR26.FthΔ/Δ 
mice succumbing 50 days after Tamoxifen administration. While these technical issues prevent 
from drawing firm conclusions at this point, the data suggests that Fth-competent CX3CR1
+ 
macrophages are important to sustain homeostasis when expression of Fth is deleted in 





Figure 3.8. Fth deletion in CX3CR1+ monocytes/macrophages. A) Survival curve of Cx3cr1CreER-
T2Fth∆/∆R26.Fth∆/∆ (n=11) and control Fthlox/loxFthlox/lox (n=5) and Fthlox/loxR26.Fth∆/∆ (n=7) mice 
after deletion with a prolonged administration of Tamoxifen by oral gavage (1mg of Tamoxifen/mouse 
for 2 times a week during 3 weeks). Body weight and temperature of these mice is presented in B) and 
C) respectively. D) Survival curve of Cx3cr1CreER-T2Fth∆/∆R26.Fth∆/∆ (n=5) and control 
Fthlox/loxFthlox/lox (n=2) and Fthlox/loxR26.Fth∆/∆ (n=6) after deletion with Tamoxifen food. Mice 
were exposed to Tamoxifen food (360mg/kg) twice for one week, interrupted by one week of standard 




3.4. Generation and characterization of a transgenic tagged-FTH protein. 
Macrophages can secrete ferritin (Cohen et al., 2010) which is then transferred to tissues as 
an additional mechanism of Fe distribution and recirculation (Cohen et al., 2010; Meyron-Holtz 
et al., 2011). To assess if this process was active in vivo and eventually responsible for the survival 
of Fthlox/loxR26.FthΔ/Δ mice, the host laboratory generated a transgenic mouse model in which 
FTH was tagged with a 14 amino-acid V5 peptide derived from the RNAa (alpha) subunit of the 
simian parainfluenza virus type 5 (Southern et al., 1991), henceforth referred to as V5 
(Figure 3.9A). For this purpose, genetic modification of the Fth locus was achieved by 
CRISPR/Cas9 technology, a highly efficient methodology for genetic manipulation (Jinek et al., 
2012). Briefly, bacterial Cas9 nuclease along with a specifically engineered guide RNA can be 
targeted to cleave any double strand DNA sequence of interest as long as there is recognition of 
the targeted DNA sequence by the guide RNA (Jinek et al., 2012). These, along with a protospacer 
adjacent motif (PAM), were the only necessary components to induce Cas9 mediated cleavage of 
the DNA sequences (Mali et al., 2013). This allows for highly efficient and precise gene editing 
(Wang et al., 2013; Yang et al., 2013). Thus, Cas9 mRNA, specific single-guide RNA (sgRNA) 
targeting the 5’ end of the Fth gene and a corresponding oligo, containing the V5 sequence flanked 
by sequences homologous to the insertion site, were co-injected into mouse zygote cells. DNA 
cleavage by the Cas9 enzyme induced the cell autonomous homology directed repair (HDR) 
mechanisms, leading to homologous recombination and in some cases the incorporation of the 
V5 containing oligo into the DNA sequence. (Figure 3.9A). The insertion of the tag in the N-
terminus of FTH was chosen over the C-terminus since the N-terminus of FTH extends outwards, 
from the protein cage complex and does not play a role in protein-protein interactions (Zhang and 
Orner, 2011). After injection, the blastocysts were transplanted into foster mothers (Figure 3.9B) 
and pups were born 21 days later.  
 
Figure 3.9. Generation of V5-FTH mice by CRISPR/Cas9. A) Schematic representation of the V5 
insertion on the Fth gene locus. Orange letters represent the start codon ATG of the Fth gene and the 
DNA sequence of the V5 epitope is shown in green. Diagram also depicts overall structure of the Fth 
gene locus. Exons are represented as blue boxes and introns as the space between the assorted exons. 
B) Generation of mice with the V5 insertion through targeted mutation by the CRISPR/Cas9 system. 
Cas9 mRNA, sgRNA and V5 oligonucleotides were inserted into fertilized eggs, after formation of the 
blastocyst the embryos were transferred into foster mothers. Courtesy of Birte Blankenhaus. 
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After birth, V5 screening by PCR allowed the identification of two positive V5 mice that 
were named #5 and #13 (Figure 3.10A). The V5-tagged mice were able to survive and showed 
no apparent visible disadvantage compared to normal mice arguing for a functional FTH protein 
which otherwise would result in embryonic lethality (Ferreira et al., 2000). Further PCR analysis 
using a polyacrylamide gel for improved resolution of the DNA bands, showed that both mice, 
the original male #13 and female #5 were heterozygous for Fth and in addition present bands that 
might be the result of off-target events occurring during the recombination process or 
modifications of the second Fth allele. (Figure 3.10B). To generate V5-Fth mice on a clean B6 
background male #13 (founder 1) and female #5 (founder 2) were crossed with C57BL/6 mice to 
generate heterozygous progeny containing the tagged V5-Fth and an Fth wild type allele 
(Figure 3.10B). These mice were then crossed with littermates to produce V5 heterozygous 
(Fthwt/V5) and V5 homozygous (FthV5/V5) progeny. 
 
Figure 3.10. Identification and breeding of V5 positive mice after CRISPR/Cas9. A) V5 screening 
by PCR using V5 forward and FTH reverse primers to genotype genetically modified pups. Two mice 
(#5 and #13) showed positive bands for the V5 insertion. B) Breeding strategy used to obtain V5-FTH 
mice on a pure C57BL/6 background. Female #5 and male #13 were appointed FD1 (Founder 1) and 
FD2 (Founder 2), respectively, and were crossed with WT mice to obtain two pure heterozygous V5 
lines. Each PCR represents the genotyping of the FTH locus in each of the V5 mice depicted above. 
Circular arrows represent intercrossing of littermates with each other. 
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The Fthwt/V5 and FthV5/V5 mice could be distinguished from wild type (Fthwt/wt) mice and within 
themselves by PCR (Figure 3.11A). It was also possible to identify the V5 epitope by western 
blot using anti-V5 Abs (Figure 3.11B). Due to the difference in molecular weight, i.e. about 1kDa 
added by the fusion of the V5 peptide, it was also possible to visualize two bands in heterozygous 
mice, when using anti-FTH Abs showing the distinction between the lighter wild type FTH 
proteins from the heavier V5-FTH fusion proteins (Figure 3.11C). Finally, we further tested the 
localization of the V5-FTH protein by immunofluorescence staining in liver sections 
(Figure 3.11D). Liver sections from wild type C57BL/6 mice showed no signal for the V5-tag, 
although a strong FTH signal was detected (Figure 3.11D, top panel). In V5-tagged mice, FTH 
and V5 stainings overlapped confirming the success of the CRISPR-Cas9 strategy (Figure 3.11D, 




Figure 3.11. Identification of V5 sequence and protein by PCR, western blot and 
immunofluorescence. A) Representative PCR from Fth screening of mice obtained from the breeding 
of one of the two heterozygous crossings. V5 identification is easily distinguished from wild type mice 
(Fthwt/wt) by the different molecular weight caused by the added V5 tag on one of the Fth alleles 
(Fthwt/V5) or both Fth alleles (FthV5/V5). V5 epitope (B) and FTH (C) staining by western blot in heart 
and kidney extracts of C57BL/6 wild type and Fthwt/V5 mice. B-actin was used has loading control. D) 
Representative immunostaining of liver sections of Fthwt/wt and Fthwt/V5 mice. Staining’s for FTH (red), 
V5 (green) and DNA (blue) are shown in C57BL/6 (D, top panel) and Fthwt/V5 (D, bottom panel) mice 
under homeostatic conditions. Merge panels show overlay of FTH (red), V5 (green) staining as well as 
DNA staining by DAPI (not shown). 
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3.5. FTH is not delivered by macrophages to parenchyma tissues. 
To investigate whether FTH transits from macrophages to parenchyma cells, when parenchyma 
cells lack Fth expression, lethally irradiated Fthlox/lox and R26.FthΔ/Δ mice were transplanted with 
bone marrows from Fthwt/V5 and FthV5/V5 mice (Figure 3.12A). Bone marrow reconstitution was 
confirmed by flow cytometry. Relative numbers of circulating monocytes, neutrophils, T and B 
cells in FthV5/V5Fthlox/lox and FthV5/V5R26.FthΔ/Δ mice were similar to those of  
Fthlox/loxFthlox/lox or Fthlox/loxR26.FthΔ/Δ chimeric mice (Figure 3.12B, C).  
 
Figure 3.12. Reconstitution by V5-Fth bone marrow. A) Schematic representation of the generation 
of V5heterozygous (Fthwt/V5) and V5homozygous (FthV5/V5) chimeric mice. V5-Fth bone marrow was collected 
from donor mice and administered to Fthlox/lox and R26CreER-T2FthΔ/Δ recipient mice. B) Relative 
percentage of leukocytes in each of the four groups after reconstitution. C) Representative FACS plots 
for the analysis of leukocyte populations in bone marrow chimeric mice. Monocytes, Neutrophils, T 
and B cell populations were identified using CD11b, Ly-6G/Gr-1, TCR-b and CD19 Abs, respectively. 
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No differences in survival were registered (Figure 3.13A), after deletion by Tamoxifen as well as 
normal ranges of weight (Figure 3.13B) and temperature (Figure 3.13C) showing that the V5-Fth 
bone marrow cells keep their ability to rescue R26.FthΔ/Δ hosts.  
To test whether macrophages could actively deliver FTH to tissues, either in normal or Fth-
deleted conditions, we detected the V5-FTH fusion protein by immunofluorescent imaging in 
livers of chimeric animals. For accurate identification of tissue macrophages, Abs directed against 
F4/80 were tested in the liver of wild type mice using a previously described immunofluorescence 
protocol on paraffin sections (Figure 3.11D). Unfortunately, it was not possible to obtain a 
positive staining for F4/80 using this experimental setup (Figure 3.14).  
 
Figure 3.13. Survival, body weight and temperature curves of V5-Fth chimeric mice A) Survival 
curve from both Fthwt/V5Fth∆/∆ (n=3), FthV5/V5Fth∆/∆ (n=4) and controls Fthwt/V5Fthlox/lox (n=2) 
and FthV5/V5Fthlox/lox (n=3) groups showing no differences 30 days of deletion (1mg/mouse of 
Tamoxifen by oral gavage 3 times in the course of one week). Bodyweight and temperature of these 
mice is presented in B) and C) respectively. 
 
Figure 3.14. F4/80 staining in paraffin section. Representative immunostaining of liver sections 
stained with FTH (red) and F4/80 (green) antibodies in a C57BL/6 wild type mouse. No signal for F4/80 





Therefore, a different protocol was employed which involved fixation of the organs with 4% PFA 
followed by tissue embedding in low melting agarose. Thicker sections of the liver were also cut 
as described in (Cardoso et al., 2017). Abs directed against CD68, a well-established macrophage 
marker (Holness et al., 1993) were also utilized. Using this strategy, we found that 
FthV5/V5Fthlox/lox mice showed a normal staining for FTH in the tissues, i.e. mainly hepatocytes 
and some interstitial immune cells most likely Kupffer cells. Interestingly, V5 staining was 
restricted to F4/80+ and CD68+ macrophages (Figure 3.15A). There was no FTH staining in 
hepatocytes from FthV5/V5 R26.FthΔ/Δ mice (Figure 3.15A). Instead, a strong staining of FTH 
could be detected in cells that were morphologically similar to Kupffer cells (Figure 3.15). 
Similarly, no V5 staining was found in hepatocytes whereas V5 expression was also detected in 
F4/80+ and CD68+ cells (Figure 3.16). In fact, both F4/80+ (Figure 3.16A) and CD68+ 
(Figure 3.16B) macrophages accumulated in larger numbers in FTH-depleted tissues than in FTH 
competent tissues (Fig 3.16A, B). In addition, these cells show a strong V5 staining, indicating 
recruitment and infiltration of bone marrow derived monocytes into the tissues, rather than 
proliferation of resident macrophage populations, in response to Fth deficiency. This increased 
expression of V5 in F4/80+ and CD68+ cells also indicates the increased expression of FTH in 
these cells and therefore hints to a compensatory mechanism that these cells employ in order to 
detoxify the tissues from otherwise deleterious iron concentrations (Figure 3.16A, B). 
 
Figure 3.15. FTH and V5-FTH detection in liver sections. Representative whole-mount 
immunostaining showing FTH (red) and V5 (green) expression in the liver of FthV5/V5Fthlox/lox (top 
panel) and FthV5/V5FthΔ/Δ
 
(bottom panel) mice. The right panel in each row shows the overlay (merge) 




Altogether, these data demonstrate that FTH does not transit from macrophages to parenchyma 
cells at steady state or in a situation where parenchyma cells lacks Fth expression. Moreover, 
macrophages seem to upregulate Fth when parenchyma cells lack Fth expression. Presumably 
macrophages react to the lack of Fth expression in parenchyma tissue, most likely contributing to 
maintain tissue iron homeostasis and avoid Fe-driven oxidative stress that otherwise compromises 
systemic homeostasis. 
 
Figure 3.16. F4/80, CD68 and V5-FTH detection in liver sections. Representative whole-mount 
immunostaining showing A) F4/80 (red) + V5 (green) and B) CD68 (red) + V5 (green) expression in 
the liver of FthV5/V5Fthlox/lox (top panel) and FthV5/V5R26.FthΔ/Δ (bottom panel) mice. The genotypes 
are shown side by side and the last panel in each rectangle (indicated as “Merge”) shows the overlay of 




Ferritin is an important regulator of intracellular Fe homeostasis, limiting Fe-assisted ROS 
generation via the Fenton reaction. Constitutive deletion of Fth in mice is embryonically lethal 
and therefore lack of Fth expression can be incompatible with life (Ferreira et al., 2000). 
Interestingly, conditional Fth deletion in liver and leukocytes leads to liver dysfunction and 
damage but not to death (Darshan et al., 2009). To investigate the effects of global Fth deletion 
in adult mice we used the R26CreER-T2Fthlox/lox (R26.FthΔ/Δ) mice that allow for temporal control of 
Fth deletion, circumventing embryonic lethality associated with germline encoded deletion. We 
confirmed that Tamoxifen induced a global repression of Fth mRNA in all the tissues of 
R26.FthΔ/Δ mice (Figure 3.2A). Of note, the brain of R26.FthΔ/Δ mice had about 70% reduction of 
Fth mRNA expression, as compared to control Fthlox/lox mice. Since R26 is an ubiquitous promoter 
and Tamoxifen can effectively penetrate the blood-brain barrier and access brain tissue (Hayashi 
and McMahon, 2002), we speculate that the higher levels of FTH expression in this organ are due 
to increased Tamoxifen degradation in the brain of adult mice (Valny et al., 2016). 
These results represent an improvement in terms of achieving global Fth deletion, over 
previous studies using a Cre recombinase system under the Mx dynamin-like GTPase 1 (Mx1) 
promoter (Darshan et al., 2009). In this study, the authors reported Fth deletion in the spleen, liver 
and bone marrow, but not in the heart, kidney and lung. Although the Mx1 promoter is present in 
virtually all cell types, its activation is under the control of type I interferon (alpha and beta) 
signaling and can be strongly activated by Poly-IC, a double stranded RNA analog recognized by 
TLR3 and potent interferon inducer (Kuhn et al., 1995). However, deletion efficiency shows high 
variability in some organs, and only the liver and hematopoietic organs  show efficient Fth 
deletion (Darshan et al., 2009), possibly due to stronger interferon responses in these tissues or 
overall interferon availability (Kuhn et al., 1995). Therefore, the mice generated in our study 
represent a more robust system to study total deletion of Fth. To further test if Fth deletion was 
reflected at the protein level, we monitored the levels of Fth protein expression in heart, kidneys, 
lungs and liver of deleted mice by western blot (Figure 3.2B-E). We confirmed that Fth can be 
successfully deleted in R26.FthΔ/Δ vs. control Fthlox/lox mice, except in the kidney (Figure 3.2D) 
where one of the R26.FthΔ/Δ mice expressed very high levels of FTH, likely owed to defective Fth 
deletion.  
FTH protein levels in the heart of R26.FthΔ/Δ vs. control Fthlox/lox mice are not reduced to the 
same extent as compared to the mRNA levels (Figure 3.2A). Presumably this is due to a higher 
FTH protein stability owed to lower turnover due to decreased protein degradation or due to a 




Having assessed the efficiency of Fth deletion in these mice, the next step was to characterize 
their phenotype. Upon Tamoxifen administration, R26.FthΔ/Δ mice lost body weight and 
temperature (Figure 3.3A, B), succumbing within 16 days (Figure 3.3C). In addition, these mice 
also showed high levels of tissue damage, oxidative stress and heart dysfunction (Birte 
Blankenhaus, unpublished data). This was not due to Tamoxifen administration per se, since 
tissue damage was not observed in control Fthlox/lox mice that received Tamoxifen at the same 
dosage and schedule. This suggests that ferritin is essential to support homeostasis during 
adulthood.  
Given that macrophages are thought to play an important role in the maintenance of Fe 
metabolism (Soares and Hamza, 2016), we hypothesized that Fth expression by macrophages 
may be essential to support homeostasis during adulthood. We tested this hypothesis using 
chimeric mice in which Fth expression is restricted to hematopoietic vs. parenchyma cells. 
Surprisingly, reconstitution of R26.Fth Δ/Δ mice with bone marrow cells from Fthlox/lox mice 
expressing Fth rescued Tamoxifen-induced loss of body weight and temperature and more 
importantly the lethality associated with Fth deletion in the parenchyma cells of chimeric 
Fthlox/loxR26.FthΔ/Δ mice (Figure 3.4B). In contrast reconstitution of R26.Fthlox/lox mice with 
bone marrow from LysMCreFthΔ/Δ mice failed to rescue Tamoxifen-induced loss of body weight, 
temperature and lethality associated with Fth deletion in the parenchyma cells of chimeric 
LysMCreFthΔ/ΔR26.FthΔ/Δ mice (Figure 3.4B). Moreover, western blot analysis showed that an 
important proportion of FTH protein expression in these mice derives from the myeloid 
compartment (Figure 3.5A-D). This is particularly evident for the liver (Figure 3.5A), kidneys 
(Figure 3.5C) and lungs (Figure 3.5D) of LysMCreFthΔ/ΔR26.FthΔ/Δ vs. Fthlox/loxR26.FthΔ/Δ 
mice with LysMCreFthΔ/Δ R26.FthΔ/Δ mice having a reduced level of FTH protein expression as 
compared to Fthlox/loxR26.FthΔ/Δ mice (Figure 3.2B-E). This likely explains the lethality of 
chimeric LysMCreFthΔ/ΔR26.FthΔ/Δ vs. Fthlox/loxR26.FthΔ/Δ mice. Further, 
Fthlox/loxR26.FthΔ/Δ mice showed an overall 60% decrease of FTH levels in the heart, while FTH 
expression in the hearts of LysMCreFthΔ/ΔR26.FthΔ/Δ mice drops more than 80%, as compared 
to the levels of FTH expression in the hearts of control Fthlox/loxFthlox/lox mice. 
Given the high level of sensitivity of cardiomyocytes to Fe toxicity (Nairz et al., 2017) and 
the important role played by macrophages in maintaining cardiac function (Nahrendorf and 
Swirski, 2016; Hulsmans et al., 2017) we conclude that FTH expression in macrophages that 
populate the heart cannot drop below a certain level, without compromising organismal 
homeostasis. It is also possible that a different hematopoietic-derived cell population might 
supply the heart with FTH. Of note, Tamoxifen-induced Fth deletion in the heart is not as effective 
as in other tissues, as illustrated by residual levels of Fth mRNA after Tamoxifen administration 
to R26.Fth Δ/Δ mice (Figure 3.2A).  
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Overall these results suggest that while most of the tissue ferritin comes from parenchyma 
cells, mice lacking Fth expression in parenchymal cells can survive provided that myeloid cells 
express Fth. However, Fth deletion in parenchyma cells becomes lethal when Fth expression is 
also deleted from myeloid cells, as illustrated for the lethality of chimeric 
LysMCreFthΔ/ΔR26.FthΔ/Δ vs. Fthlox/loxR26.FthΔ/Δ mice (Figure 3.4B). This is in line with 
previous studies showing that lack of Fth expression in parenchyma tissues can lead to increased 
accumulation of labile Fe and consequently ROS formation, as illustrated for intestinal epithelial 
cells (Vanoaica et al., 2010) as well as hepatocytes (Darshan et al., 2009). Moreover, macrophages 
have also been shown to contribute in reducing muscle damage by a mechanism involving the 
upregulation of Fth (Corna et al., 2016). 
Having established that expression of Fth by myeloid cells can compensate for the lack of 
Fth expression in parenchyma tissues (Figure 3.4B) we asked what would be the specific myeloid-
derived population involved. Although the relative contribution of different monocyte subsets to 
the overall composition of tissue resident macrophages remains unclear (Kierdorf et al., 2016) 
several studies suggest that blood circulating monocytes can replace tissue-resident macrophages, 
when these are deleted following damage or infection (Blériot et al., 2015; Bruttger et al., 2015). 
This requires that monocytes migrate from the bone marrow and infiltrate tissues, via  a CCR2-
dependent  mechanism, likely involving the chemokine monocyte chemoattractant protein-1 
(MCP-1, also known as CCL2) (Serbina and Pamer, 2006; Tsou et al., 2007; Varol et al., 2015). 
When lethally irradiated R26.FthΔ/Δ mice were reconstituted with bone marrow from Ccr2-/- mice 
there was a decrease in body weight (Figure 3.6C) and temperature (Figure 3.6D) as well as 
reduced survival of chimeric Ccr2-/-R26.Fth∆/∆ mice, as compared to Fthlox/loxR26.Fth∆/∆ mice 
(Figure 3.6B). This effect was only observed after a more extended time span, as compared to 
chimeric LysMCreFthΔ/ΔR26.FthΔ/Δ mice (Figure 3.4B), which succumbed within 40 days of 
Tamoxifen administration. We conclude that a while Ccr2+ monocytes expressing Fth are 
important to maintain homeostasis there is probably a subset of monocytes that migrates into 
damaged tissues independently of Ccr2 expression and signaling, where they mitigate tissue 
damage, likely by sustaining residual Fth activity in situ. This conclusion is also supported by a 
previous report showing that the spleen acts as a reservoir for a specific subset of monocytes 
which are able to migrate to, and infiltrate damaged tissues independent of Ccr2 signaling 
(Swirski et al., 2009). Unfortunately, experiments using splenectomized mice aimed at testing 
this hypothesis failed to generate conclusive data, due to technical constrains (Figure 3.7A). 
Therefore, further investigation is required to clarify our hypothesis. 
Despite intensive investigation, macrophage ontogeny remains controversial. The prevalent 
theory for several decades was that macrophages develop exclusively from circulating monocytes 
(van Furth, 1976). However, recent reports have shown that tissue-resident macrophages are 
established before birth (Samokhvalov et al., 2007; Hoeffel et al., 2012; Gomez Perdiguero et al., 
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2014). With the exception of microglia and intestinal macrophages, tissue-resident macrophage 
progenitors migrate and establish populations in fetal tissues before birth via a mechanism that 
requires Cx3cr1 expression (Yona et al., 2013). Moreover, a subset of monocytes expressing high 
levels of Cx3cr1 has been identified (Geissmann et al., 2003) and shown to migrate from the bone 
marrow to adult tissues where they act as precursors for tissue-resident macrophages, 
differentiating into various specialized macrophage subtypes (Geissmann et al., 2003). However, 
regardless of their origin, tissue-resident macrophages have self-renewable capabilities which are 
mainly independent from circulating monocytes (Hashimoto et al., 2013).  
With the objective of understanding the contribution of tissue-resident macrophages in the 
rescue of R26.Fth∆/∆ mice, two different strategies were used to delete Fth in chimeric 
Cx3Cr1CreER-T2Fth∆/∆R26.Fth∆/∆ mice. The first one involved continuous Tamoxifen 
administrations during three weeks (Figure 3.8A-C) and the other involving continuous 
Tamoxifen administration in food (Figure 3.8D-F). The side effects of Tamoxifen administration 
is a widely recognized complication of the inducible CreER-T2 system and has been associated with 
tissue damage in mice (Huh et al., 2012; Gao et al., 2016). Deletion of Fth in chimeric 
Cx3Cr1CreER-T2Fth∆/∆R26.Fth∆/∆ mice was associated with lethality using both Tamoxifen 
strategies. This was also the case for Fthlox/loxR26.Fth∆/∆ mice, which undermines the 
interpretation of the results. Considering the already deleterious modifications performed on the 
recipient animals due to irradiation, one reason these animals fail to survive could be due to their 
increased susceptibility to tissue damage owing to a more stringent Tamoxifen regime. Another 
possible explanation is that the increased Tamoxifen administration regimen could lead to 
complete Fth deletion in the brain. This is consistent with the observation that the same regimes 
of Tamoxifen administration are not lethal to control Fthlox/loxFthlox/lox mice. One way this 
technical problem could be circumvented is by using Cx3cr1CreFthlox/lox animals where Fth is 
constitutively deleted from Cx3cr1
+ cells, allowing to compare under low Tamoxifen regimen the 
outcome of Fth deletion in Cx3Cr1CreFth∆/∆R26.Fth∆/∆ vs. Fthlox/loxR26.Fth∆/∆ mice. These 
experiments are underway. 
Although the use of Cx3Cr1CreER-T2Fth∆/∆ mice as bone marrow donors did not generate 
conclusive results, the data generated with Ccr2-/- mice showing that monocyte migration into 
parenchyma tissues is required to sustain survival (Figure 3.6B), strongly points towards a role of 
tissue macrophages to compensate the loss of Fth expression by the parenchyma cells. This is in 
accordance with recent reports showing that macrophage migration to parenchyma tissues 
alleviates Fe-related tissue damage and inflammation (Bolisetty et al., 2015; Corna et al., 2016; 
Theurl et al., 2016). 
Under homeostatic conditions, macrophages can secrete ferritin into circulation acting as the 
main source of serum ferritin (Cohen et al., 2010). This mechanism has been proposed as an 
alternative strategy for Fe delivery into tissues (Meyron-Holtz et al., 2011). In vitro studies also 
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showed that in the absence of transferrin, macrophage secreted ferritin is taken up by cultured 
erythroid precursor cells and used as a source of Fe in erythroid development (Leimberg et al., 
2008). In vitro experiments have also shown that ferritin released from Kupffer cells have a high 
Fe content and can be internalized by hepatocytes (Sibille et al., 1988). In keeping with these 
findings a FTH receptor has been identified in mice, enabling FTH internalization by endocytosis 
by hepatocytes, kidney epithelial cells as well as in B and T cells (Chen et al., 2005). Moreover, 
ferritin can be associated with microtubules in a wide range of cells (Hasan et al., 2006; Infante 
et al., 2007) which could hint that a mechanism for intracellular ferritin trafficking exists that 
allows its mobilization after internalization. To further investigate the mechanism supporting the 
survival of Fthlox/loxR26.Fth∆/∆ mice, the host laboratory generated transgenic mice in which 
endogenous FTH is fused to a V5 tag peptide (Figure 3.9A). This strategy allowed determining 
the origin of FTH according to detection of the V5 tag. With this purpose, we tracked V5-FTH 
expression in FthV5/V5Fthlox/lox mice, to assess whether secreted FTH is transferred from the 
hematopoietic compartment into parenchyma cells in vivo. Since ferritin is a large multimeric 
structure composed of two different subunits there was the possibility that the insertion of the V5 
tag would interfere with the self-assembly process of the multimeric complex. While it has been 
shown that small deletions in both N and C terminus of recombinant human FTH did not interfere 
with this self-assembly or ferroxidase ability (Levi et al., 1988), the effects of the fusion of the 
mouse FTH protein with a V5 peptide have never been assessed before. Heterozygous Fthwt/V5 or 
homozygous FthV5/V5 mice were viable and healthy and did not show any apparent phenotype 
when compared to Fthwt/wt mice (Birte Blankenhaus, unpublished data). This argues strongly for 
the correct functionality of the V5-FTH tagged protein. 
As the V5 tag adds 14 amino acids (aa) to the FTH protein, the V5-Fth and the Fth alleles 
can be easily distinguished by PCR (Figure 3.11A) as well as by western blot analysis 
(Figure 3.11B). Surprisingly, the western blot performed in extracts from heterozygous Fthwt/V5 
mice, using an anti-FTH Ab (Figure 3.11C) showed a different intensity on the upper vs. the lower 
molecular weight FTH band, which corresponds to the V5-FTH tagged vs. the endogenous FTH 
protein. This suggests that V5 may interfere with FTH protein expression and/or ferritin function. 
Another possible explanation is that the modifications induced by the V5 fusion could increase 
the affinity of the anti-FTH Ab for the tagged protein. Moreover, the V5 tag could cause some 
structural changes in the ferritin complex, which could make it more stable or less prone to 
clearance by the degradation machinery. Using a V5-directed Ab on paraffin sections we found 
complete co-localization of V5 and FTH on livers of V5 transgenic animals (Figure 3.11E), 
further arguing for the functionality of the tagged FTH protein.  
V5-FTH represents an important tool to characterize the ability of FTH to transit from the 
myeloid cells to the parenchyma and to gain a unique insight into the mechanism by which ferritin 
from myeloid cells provides a physiological advantage to the Fth deleted parenchyma tissues. 
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Both Fthwt/V5R26.Fth∆/∆ and FthV5/V5R26.Fth∆/∆ mice survived to a similar extent to 
Fthlox/loxR26.Fth∆/∆ mice (Figure 3.13A, 4B). This further supports that V5-FTH is fully 
functional and as such can be used as a tool to dissect the ability of FTH to transit between 
compartments. In order to answer which mechanism is used by myeloid cells to support tissue 
function in the absence of ferritin we decided to use an immunohistochemistry approach by 
staining FTH, V5 and a macrophage marker that would confirm or not the transit of the V5-FTH 
fusion protein into parenchyma cells such as hepatocytes. Macrophage, FTH and V5-FTH co-
staining required additional set up of the immunohistochemistry protocol. While Abs against V5 
and FTH proteins detected the respective epitopes on paraffin sections (Figure 3.11D), the 
macrophage marker tested failed to do so (Figure 3.14). Paraffin can interfere with the binding of 
Abs to their respective epitopes due to the chemical alterations exerted by the fixation methods 
(Zupančič et al., 2017) and although several antigen retrieval protocols have been developed (Shi 
et al., 2011), a wide variety of antigens still cannot be properly detected (Zupančič et al., 2017). 
Therefore, this generated the need for the development of a different strategy. A whole-mount 
immunohistochemistry protocol was used which was adapted from a previous described protocol 
(Cardoso et al., 2017) (Figure 3.15 A, B). Using this approach, we found that as expected, FTH 
protein expression was detected in hematopoietic and parenchyma cells of Fthwt/V5Fthlox/lox or 
FthV5/V5 Fthlox/lox (Figure 3.14). However, V5 staining was limited to cells that resemble 
morphologically myeloid infiltrating cells that express F4/80 or CD68, i.e. macrophages 
(Figure 3.15 A, B). This suggests that when expressed in macrophages FTH does not transit to 
parenchyma cells in the liver, e.g. hepatocytes. There was no detection of FTH protein in the 
parenchyma of FthV5/V5R26.Fth∆/∆ mice (Figure 3.15). FTH in these mice was limited to few 
interstitial cells suggesting that FTH does not transit from macrophages to parenchyma cells and 
instead FTH expression is limited to macrophages. As expected, all the FTH-expressing cells co-
express V5 (Figure 3.15), showing that all the expression of FTH is confined to hematopoietic 
infiltrating cells, i.e. macrophages. Moreover, FTH expressed by tissue macrophages does not 
transit to parenchyma cells. Instead, there seems to be an accumulation of FTH-expressing tissue 
macrophages expressing high levels of V5-FTH, probably compensating for the lack of FTH 
expression in parenchyma cells. Instead, parenchyma cells in these mice up regulate the 
expression of the Fe exporter FPN (Birte Blankenhaus, unpublished data), possibly to avoid 
intracellular Fe accumulation. This should generate an increase in extracellular labile Fe, which 
is probably up taken by macrophages and stored inside Ferritin. In the absence of Fth-competent 
macrophages the extracellular Fe would accumulate and act as a pro-oxidant to cause oxidative 
damage and tissue dysfunction consequently leading to death. These results go against previous 
in vitro data showing that macrophages can increase FTH secretion under conditions of Fe 
overload (Yuan et al., 2004) and that hepatocytes (Sibille et al., 1988) or human erythroid 
precursors (Leimberg et al., 2008) uptake ferritin produced by macrophages. Interestingly, given 
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that hepatocytes express the FTH receptor T cell immunoglobulin-domain and mucin-domain 2 
(TIM-2), which allows for FTH internalization (Chen et al., 2005), no FTH is seen inside these 
cells under the experimental conditions used herein (Figure 3.15 and Figure 3.16). This argues 
further that FTH is not secreted by macrophages under these experimental conditions since, as 
illustrated by the lack of V5-Fth expression in parenchyma cells, i.e. hepatocytes. Instead, Fe is 
likely loaded and stored by Fth-expressing macrophages that may then release Fe to be delivered 
into different tissues via different mechanisms. This hypothesis is in fact supported by several 
studies that show increased FPN expression in macrophages after Fe clearance, as a mechanism 
for Fe delivery to tissues (Corna et al., 2016; Theurl et al., 2016). 
Altogether these results provide insights into the overall contribution of myeloid cells, i.e. 
macrophages, to the overall level of Fth expression in different tissues. When parenchyma tissues 
lack or have significantly reduced levels of FTH protein expression bone marrow derived 
macrophages that infiltrate these tissues up regulate the expression of Fth, which is essential to 
maintain homeostasis and sustain survival. Experiments aimed at determining the specific 
myeloid population responsible for these effects yielded conflicting results, likely due to technical 
issues. As such, it remains to be established which specific Fth-expressing myeloid subset 
compensates for the lack of Fth expression in parenchyma cells. Finally, the characterization and 
development of Fth-tagged transgenic mouse strain allowed to answer one of the main questions 
proposed by this thesis, namely, whether macrophages deliver FTH into parenchyma tissues. We 
found that this is not the case. Furthermore, these transgenic mice can be a useful tool for future 
experiments aimed at understanding the biologic function of FTH. Our work reinforces the 
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